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ABSTRACT
TEST MODEL OF A HEALTHY LIFESTYLE INTERVENTION PROGRAM
by
JORIE C. ALLEN 
University of New Hampshire, December, 2012
The purpose of this study was to evaluate whether a worksite health 
promotion (WHP) delivered in a small workplace, improves health risk factors, is 
cost-effective, and positively impacts health behaviors.
Comparison (C, n = 31) and Intervention (I, n = 29) groups underwent 
health risk assessment and screening at baseline, 12 and 24 months. The I 
group attended lifestyle classes at the workplace and reported pedometer step 
counts. Data were analyzed using general linear model ANOVA or Chi square 
analysis.
At 12 months from baseline, the I group had a decreased LDL cholesterol 
(LDL-C) (126.67 ±4.0 mg/dl to 110.86 ± 4.4 mg/dl p = 0.011), and average steps 
per day increased (5253 ± 368 steps, 7149 ± 400 steps, p = 0.01). No changes 
were noted in waist circumference (WC), or metabolic syndrome (MetS) markers. 
In the C group from baseline, WC increased (37.1 ±0.4 in, 38.9 ± 0.4 in, p= 
0.001), and MetS markers increased (1.44 ±0.1, 1.88 ± 0.1 markers, p = 0.018) 
to a value that was also greater than that in the I group at 12 months (1.29 ± 0.1 
markers, p = 0.002). Dietary omega-6/omega-3 fatty acid ratio was found to be
greater than that of the I group (14.49 ±1.8; 10.33 ±2.3, p = 0.03). Cost- 
effectiveness compared favorably to other studies.
At 24 months, LDL-C and Mets markers were not different from the 12 to 
24 month values, either within or between groups. WC of the I group (37.3 in) 
was significantly less than the C group (38.7 in, p = 0.04). C-reactive protein of 
the I group was 44% less than that of the C group (p = 0.027). More of the I 
group than the C group participants reported increased physical activity (84.2% 
vs. 41.2 % , p = 0.007) and improved diet (63.2% vs. 29.4 %, p = 0.043). Both 
groups were highly receptive to a WHP.
This study demonstrated that health risks and health behaviors can 
improve following a WHP in a small workplace that is also cost-effective, and 
well-accepted by employees.
xi
CHAPTER 1: WORKSITE HEALTH PROMOTION REDUCES HEALTH RISKS
AMONG EMPLOYEES OF UNIVERSITY OF NEW HAMPSHIRE 
COOPERATIVE EXTENSION 
Introduction
A paradox of life in Westernized society is that in this age of technological 
and medical advances, there is an epidemic of lethal chronic disease. Chronic 
diseases, that include cardiovascular diseases (CVD), coronary heart disease 
(CHD), and type 2 diabetes mellitus (T2DM), are leading causes of death. 
Metabolic syndrome (MetS), a clustering of risk factors for all of these conditions 
is increasing in prevalence, as well. The data that links modern lifestyle to these 
conditions is extensive; however, there is also a large body of evidence 
documenting that modification of diet and physical activity can delay onset, 
prevent, or even reverse these disorders (1). Based on risk factor identification, 
these conditions are predictable; and importantly, they are also preventable (2, 
3).
In 2006, cardiovascular disease (CVD) was estimated to affect 37% of the 
population. It was the leading cause of death, and ranked highest among all 
disease categories in hospital discharges. CVD claims more lives each year than 
cancer, chronic lung disease and accidents combined and was estimated to
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generate costs of over $503 billion in 2010. The CVD category of illnesses is 
broad and includes (CHD), hypertension and stroke (4).
Additionally in 2006, diabetes affected 23.5 million US adults; cost was 
$174 billion and was the seventh-leading cause of death. However, it is widely 
believed that diabetes as a cause of death is underreported, since it is a major 
factor in CHD, stroke and hypertension. CVD is the leading cause of death in 
people with T2DM; adults with diabetes have heart disease death rates about 
two to four times higher than adults without diabetes (5).
The metabolic syndrome (MetS) is an additional cardiometabolic risk 
condition that is defined by markers of dyslipidemia, hypertension, hyperglycemia 
and central obesity. The clustering of these factors indicates the presence of both 
prothrombotic and proinflammatory states. When present, MetS increases by 
twofold the likelihood of developing CVD, and for T2DM, fivefold (6). 
Approximately 34% of US adults over the age of twenty are believed to have 
MetS (7). According to a recent update on the revised guidelines of the Third 
Report of The National Cholesterol Education Program (NCEPIII), MetS patients 
have an average 10-year risk for a first CHD event of up to 18%; and persons 
with diabetes should be treated as though it were the risk equivalent of existing 
CHD (8).
An elevated level of blood low-density lipoprotein cholesterol (LDL-C) is a 
risk factor that is common to both CHD and T2DM and frequently coexists with 
MetS. In 2009, it was estimated that approximately 36.7 million U.S. adults have 
high LDL-C levels (> 160 mg/dl), with an additional 30.8 million having borderline-
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high levels ( l .160 mg/dl and >130 mg/dl) (9). NCEP III has identified that the 
principal target for coronary heart disease (CHD) risk reduction is the control of 
LDL-C (3).
The greatest benefit in risk reduction through the lowering of LDL-C is 
derived from early intervention, because CVD develops over many years before 
symptoms become apparent (10). Vascular damage occurs in stages, beginning 
with the accumulation of modified LDL-C within an arterial wall. Over time, the 
growing lesion can narrow the vessel lumen. Epidemiological studies have 
demonstrated that LDL-C levels correlate with CVD risk, and combined analyses, 
indicate that for every 1% reduction in LDL-C, there is a reduction in CHD risk of 
at least 1% which is independent of baseline LDL-C levels (11-13).
The inflammatory biomarker, C-reactive protein (CRP) also is predictive 
of disease outcomes in individuals and may be as important as LDL-C in terms of 
risk assessment (14, 15), even in apparently healthy individuals (16), Because 
vascular damage is an inflammatory process, proliferation and migration of cells 
lead to plaque formation. When the expanded plaque ruptures, the vessel fills 
with a thrombus, causing occlusion and can result in ischemia or infarction (17). 
Arterial occlusion can occur without warning, even in asymptomatic individuals.
CRP was found to be a strong predictor of the development of T2DM in the 
Nurse’s Health Study (18). In addition, that study determined that undiagnosed 
vascular damage can be present for up to fifteen years before a diagnosis of 
T2DM is made in women (19). Changes in dietary pattern that included a 
reduced consumption of trans fats (82) and a lower ratio of n-6 to n-3 fatty acids
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(75) have been associated with both improved LDL-C and CRP following lifestyle 
intervention studies.
Risk factor modifications have been shown to reduce morbidity and 
mortality from CVD (10), but it is necessary to identify those individuals at risk. 
Data from the National Health and Nutrition Examination Survey (NHANES) from 
1999 - 2006 show that one-third of the participants with elevated LDL-C were 
previously unscreened and had missed an opportunity to improve their status. 
Additionally, one-fourth of those that were screened and had elevated LDL-C, 
were never told by their health care provider that their cholesterol was high (20). 
Younger adults, ages 20 -  44 years had a particularly low screening rate 
regardless of other risk factors (21). A study, that assessed screening rates 
among 5,025 male and female adult primary care patients (mean age 47.4 
years), found that only 40% were screened for LDL-C. Women, in particular, 
were underscreened for several cardiometabolic risk factors. A conclusion of the 
study was that health plans and clinical groups should examine screening 
practices and develop plans to improve screening rates (22). It is estimated that 
35% women in the United States have some form of CVD and for men, this 
number is 37.6% (23).
A lifestyle that limits or does not permit the development of risk factors is 
the preferred method to lower cardiovascular risk (24). However, the Health 
Belief Model states that individuals must feel susceptible to a disease or 
condition before they will take action to decrease their risk. This model relies on 
assumptions that the individual is aware of what the hazards are in general, and
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is able to self-assess their personal risk and confidently begin therapeutic 
lifestyle change (25). Research has demonstrated that there is a general lack of 
awareness of healthy levels of risk factors for CVD, and that most individuals do 
not know their own degree of risk (26, 27).
Conversely, improved awareness is known to increase actions to lower 
CVD risk (27). Furthermore it has been shown, that when individuals are 
identified as at-risk for the development of CVD and T2DM and are shown how to 
make lifestyle changes, risk can be significantly reduced (28). It stands to reason 
that an intervention program designed to reduce health risks by increased 
awareness and lifestyle changes could be successful and impact the progression 
of either CVD or T2DM. In the case of prediabetes, an identifiable condition that 
precedes the diagnosis of T2DM, lifestyle changes are shown to be even more 
effective than treatment with medication (29). Interventions with the common goal 
of reducing risk factor prevalence for CVD and T2DM, affect other chronic 
diseases such as dyslipidemia, hypertension and obesity. A review of preventive 
interventions reported that effective primary prevention treatments for T2DM are 
effective in those chronic conditions, as well (30). Despite the strong evidence 
supporting the promotion of a healthy lifestyle to prevent chronic disease, 
dissemination and implementation of intervention programs have been 
problematic because there are few options that are low-cost and commonly 
accessible.
The Centers for Disease Control and Prevention (CDC) suggest that 
worksites are uniquely positioned to provide effective programs that improve
5
health, because more than one-half of waking hours are spent at work.
Therefore, employees are a potential captive audience for programs that include 
health screenings and educational sessions (31). In 2009, an estimated 60% of 
U.S. adults older than 18 years were employed; and of those, 16% were older 
than 65 years (32). In fact, worksite health promotion (WHP) has been shown to 
successfully educate employees, screen, and reduce risk for the development of 
chronic disease (33-37).
Goetzel et al. found that employees with modifiable lifestyle risk factors 
cost employers 228% more in health care costs relative to risk-free employees 
(38). Multiple studies have shown that health care costs and absenteeism are 
decreased when employee’s heath risks are reduced through WHP (39). In 2005, 
it was reported that participants in WHPs had 25% - 30% lower medical and 
absenteeism costs compared to non- participants (40). Moreover, a 2010 meta­
analysis of twenty-two studies on cost savings, associated with WHPs, found that 
the average employer yielded cost-savings of $358 per participating employee in 
2009 dollars (41). Because most of the studies evaluated in the aforementioned 
review were implemented by large employers (more than 1,000 employees), 
these positive findings might not pertain to smaller employers. Currently, eighty- 
five percent of U.S. employers have fewer than 100 employees (42). From the 
perspective of the smaller employer, it would be important to determine not only 
that an employer-sponsored wellness program improves the health of 
employees, but that it is also cost-effective when compared to the potential 
consequences of deteriorating employee health.
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The purpose of the following intervention study was to evaluate the impact 
and cost- effectiveness of a lifestyle intervention program on the health status of 
the employees of a small (172 employee), decentralized organization. Our 
worksite health promotion (WHP) assessed CHD risk in employees of University 
of New Hampshire Cooperative Extension (UNHCE), and provided an 
educational intervention to promote healthy lifestyle changes.
Research Objectives
A two-year intervention study of consecutive twelve-month periods was 
designed to: 1) evaluate the impact and cost-effectiveness of a lifestyle 
intervention program on the health status of employees of UNH Cooperative 
Extension (UNHCE) in year one and, 2) determine if any positive changes in 
lifestyle, clinical measurements and health risk factors achieved after 1 year in 
employees of UNHCE are sustained in year two.
Methods 
Randomization /  Allocation
UNH Cooperative Extension is based on the UNH Durham campus; 
however, it has ten additional regional worksites throughout the state of New 
Hampshire. Participants were recruited from all of the UNHCE offices, sixty-four 
of the 172 employees (37%, 6 male, 58 female) from ten sites volunteered. 
Assignment of subjects to treatment groups was dependent on site; 18 
volunteers from the five out of ten total sites that had no access to 
videoconferencing were assigned, by default, to the Comparison (C) group.
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Volunteers from the remaining sites were randomized on a proportional basis to 
either the Intervention (I) or C group. This allocation resulted in C and I groups of 
32 subjects, each. Subjects signed an informed consent document and were not 
compensated. The use of human subjects in this study was approved by the 
University of New Hampshire (UNH) Institutional Review Board for the Protection 
of Human Subjects in Research (IRB). Testing was conducted at county offices 
of UNHCE or on the UNH campus. Comprehensive testing was performed at 
baseline, twelve months and 24 months with additional blood tests at six and 
eighteen months.
After randomization, but prior to baseline testing, four volunteers withdrew 
from the study (2 did not want to commit to the conditions of the study, 1 job 
change, 1 personal), leaving 31 C and 29 I participants at baseline. During year 
one, five subjects withdrew (3 personal, 2 job change), leaving 28 C and 27 I 
participants at 12 months. During year two, twelve additional volunteers (6 
personal, 4 retired, 1 job change, 1 illness) withdrew leaving 23 C subjects and 
20 I subjects at 24 months. (Figure 1.1).
Anthropometric and Biochemical Screening Tests
All participants were tested, using fingerstick samples of whole blood, 
after an overnight fast for: total cholesterol (TC), HDL-cholesterol (HDL-C), LDL- 
cholesterol (LDL-C), total cholesterol to HDL-cholesterol ratio (TCHDL), 
triglycerides (TRG) glucose (FG) and high-sensitivity C-reactive protein (hsCRP). 
Samples were analyzed enzymatically using a small, portable analyzer 
(Cholestech LDX system, Cholestech Corporation. Hayward, CA).
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Figure 1.1 Participant Allocation and Withdrawals
12 offices wttti volunteers 
| Volunteer participants n *  44 

























n « 2 »
Comparison 
n •  23
Comparison 
n -  31




to Comparison group 
n « 18






within each office 
to Comparison or Intervention group
Offices assessed lor eBgibWy for Intervention 
(access to videoconference network)
Figure 1.1 Legend - Before allocation of subjects to experimental groups, it was necessary to assess each UNHCE 
worksite individually for membership in the Granite State Distance Learning Network (GSDLN). If GSDLN was not 
available, participants from those sites received a default assignment to the comparison group. Eighteen participants 
from these offices were allocated to the comparison group. Since the number of volunteers from each of the offices 
that were part of GSDLN was different, the random selection of fourteen comparison subjects was done on a 
proportional basis, with at least one participant from each site assigned to the comparison group. This allocation 
resulted in comparison and intervention groups of 32 subjects each.
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Height and weight were measured using a portable Health-O-Meter 402 
medical beam scale with non-detachable weights and an 84” sliding stadiometer. 
Waist circumference (WC) was measured using a non-stretchable, flexible tape 
measure placed at the level of the iliac crest parallel with the floor. Measurement 
was made at the end of a normal expiration.
Percent fat mass (PCTFM), total body water percent (TBWPCT), and body 
mass index (BMI), were measured using a portable, battery-operated 
bioimpedance analyzer BIA 450, Biodynamics Corporation, Seattle, WA). The 
BMI value that is reported by the BIA 450 is based on Quetelet’s Index: Weight/ 
Heigh f  (43).
Following BIA measurement, systolic (SBP) and diastolic blood pressures 
(DBP) were measured in the right arm of subjects in the supine position, using a 
clinically approved automated oscillometric monitor (Omron HEM-711 AC(N), 
Omron Healthcare, Inc, Bannockburn, Illinois) according to standard protocols. 
Metabolic syndrome markers were counted based on the definition of MetS 
components by the NCEP ATP III. These factors included WC >102 cm. (40 in.) 
for men and > 88 cm. (35 in.) for women, HDL-C < 40 mg/dl in men and < 50 
mg/dl in women, TG > 150 mg/dl, BP > 130/> 85 mmHg and FG > 100 mg/dl 
(44). A copy of screening test results was presented to each participant and 
discussed immediately following testing.
Starting in month 5 of year one, subjects also received monthly health 
newsletters by electronic mail (e-mail) in year one: and in year two, four 
quarterly. Each issue had a particular focus such as, T2DM or MetS, and was
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written so that the purpose of the material was easily understood and in a style 
that was active and personal. (Table 1.1).
Pulmonary Function Studies
Since pulmonary function has been reported to be inversely related with 
insulin sensitivity and WC (45, 46), each participant was given and instructed in 
the use of a new, hand-held digital peak flow meter (Koko Peak Pro6, Bionostics 
Inc 7 Jackson Rd, Ayer, MA 01432) that measured peak expiratory flow rate 
(PEF) and forced expiratory volume in one second (FEN/^.
Participants were also given written, illustrated instructions and a printed 
form on which to self-record results. They were asked to perform the test at 
home in the morning and evening at the same times each day for a week in the 
month following the health screening.
Measurement of PEF and FEVi was repeated three times at each testing, with 
the highest value of the three recorded. Participants were asked to mail the 
record sheet to the primary research investigator when completed. The use of a 
handheld spirometer in research settings has been justified (47) and the 
collection of three, unsupervised efforts at a time has been found to be adequate 
(48).
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Table 1.1. Contents of UNHCE Workplace Health Promotion Newsletters
Volume T . Volume T . 
( t a K )  To* “  M  T° I " CS
•  What are the benefits of regular 
physical activity?
•  How to stay hydrated
. . . . . . .  •  If the shoe fits...
Vol-1 (1) v•  Your steps count
•  Tips for staying physically 
active
•  Take it slow
•  The body’s reaction to stress
•  Stress increases risk of illness 
Vol 1 (7) *  Stress and exercise
•  Stress and sleep
•  Ways to reduce stress
•  Wellness: what’s in it for you?
•  Metabolic syndrome, heart 
disease, diabetes
y0l 1 ,g\ •  Strategies for dealing with the 
'  '  holidays
•  Holiday recipe
•  Alcohol intake during the 
holidays
•  Increasing prevalence of 
diabetes
•  Risk factors for diabetes
Vol. 2 (1 ) •  Metabolic syndrome increases 
diabetes risk
•  Diabetes prevention
•  Exercise helps!
•  Resolutions for a healthy year
•  Components of a healthy diet: 
Carbohydrates
•  Simple vs. complex 
Vol. 1 (3) carbohydrates
•  Whole grains and fiber
•  Recipe
•  Identifying and modifying CVD 
risk
•  Atherosclerosis
•  Important considerations for 
Vol. 2 (2) women
•  Blood pressure, cholesterol and 
triglycerides
•  Heart healthy diet / good fats 
and bad fats
•  Dietary fats: why we need them
•  Good ones, not-so-good ones 
Vol. 1 (4) •  Ways to add healthy fats to
your diet
•  Recipe
•  What is stress?
•  Mind-body connection 
Vol. 2 (3) •  Stress at work
•  Stress management
•  What are proteins?
•  Sources of protein
•  Meat and meat alternatives 
y 0 l j  •  Ways to add protein to your
•  The ‘skinny’ on high protein 
diets
•  Recipe
•  Maintenance of a Healthy 
Lifestyle
Vol. 2 (4) •  Prevent the Preventable
•  Why Work at Health?
•  Why Health at Work?
•  Keep it Simple
•  What is osteoporosis?
•  What are the risk factors? 
Vol. 1 (6) •  Dietary sources of calcium
•  Calcium supplements
•  Recipe
Newsletters were formatted for and delivered by email to all WHP participants. Vol. 1 = year 1, Vol. 2. = Year 2. The 
newsletters can be viewed on the enclosed CD.
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Test values were compared to predicted normal values for PEF (49) and 
FEVi (50) using a web-based resource, the Medical Algorithms Projects 
(www.medal.org) and calculated using the equation:
Percent of predicted = (measured PEF or FEVi) /  (predicted PEF or FEVi) * 
100.
Measurement of diurnal variation of the PEF was calculated by using the 
following equations:
PEFvar = absolute value (PEFpm -  PEFam)
Average amplitude percent = (PEFvar/PEFavg) * 100
Due to a relatively poor return of completed self-reported record sheets 
(18% at 12 months) permission was sought and received from the IRB to collect 
a one-time observed measurement of PEF and FEVi performed in the presence 
of and recorded by the primary research investigator. This observed test was 
conducted at the final health screening in year two in the same manner as the 
self-reported tests. The variation between the mean self-reported tests of PEF 
and FEVi at 24 months and the researcher-observed tests at 24 months was 
calculated as a percent of the observed measure:
Self-reported measure /  researcher-observed measure *100
Diet Record Collection and Analysis
Analysis of dietary nutrients was based on self-reported three-day food 
records completed at baseline, 12 months, and 24 months. Subjects were given
full instructions for keeping a food record that included printed examples and
13
picture guides for estimating food portions. Specifically, participants were asked 
to record on the provided forms, all foods and beverages, including water, 
consumed on three typical non-consecutive days, with one of those being a 
weekend day, and to return the record to the project coordinator by mail (self- 
addressed stamped envelopes were provided). Dietary data were analyzed by a 
commercial software program with a 20,000+ food database (Diet Analysis Plus 
8.0, Wadsworth Publishing). Analyses were performed on data sets collected for 
year one (baseline to 12 months) and year two (12 to 24 months). In addition, 
separate standalone analyses were performed at baseline, 12 and 24 months. 
Results were reported as total grams consumed or as a percent of total 
kilocalories consumed and compared to Dietary Reference Intakes (DRI) for 
each individual.
Of particular interest in this investigation was energy and fat consumption, 
due to their purported influence on the risk for T2DM, CVD and MetS. Total fat 
intake was categorized according to fatty acid saturation (i.e., saturated, 
monounsaturated, polyunsaturated) and unspecified fats. The category of 
unspecified fats as defined by Diet Analysis Plus 8.0 may include any type of fat 
that is not classified as saturated, monounsaturated, or polyunsaturated by a 
food manufacturer or laboratory nutrient analysis, such as: trans fats, fractionated 
oils, phospholipids, sterols (cholesterol), glycerol, monoglycerides, and 
diglycerides. Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids 
(PUFAs) were also evaluated and used to calculate the n-6 to n-3 ratio (n-6/n-3 
ratio) as follows:
14
n-6/n-3 ratio = n-6 PUFA gms/ n-3 PUFA gms
Analysis of a subset of diet records returned by the same participants that 
completed records at both baseline and 12 months, was done to determine if 
there had been changes in consumption of food group servings. The food-group 
analysis was based on the portion sizes and categories of the former U.S. 
Department of Agriculture Center for Nutrition Policy & Promotion MyPyramid 
(www.MyPyramid.gov) as follows:
•  Fruit Group should provide 4 daily servings, or 2  cups.
•  Vegetable Group should provide 5 servings, or 2.5 cups.
•  Grain Group should provide 6 ounce-equivalents (1 ounce-equivalent 
means 1 serving), half of which should be whole grains.
•  Meat and Beans Group should provide 5.5 ounce-equivalents or 
servings.
• Milk Group should provide 3 cups/servings.
• Oils should provide 24g or 6 teaspoons.
• Discretionary Calories: The remaining amount of calories in each calorie 
level after nutrient-dense foods have been chosen.
Health Questionnaire and Exit Survey
Health Questionnaire. Self-administered questionnaires were 
distributed at baseline, 12 months and 24 months. The questionnaires were 
designed for use by the UNH Center for Health Enhancement (CHE) weight 
management program. Questions were categorized as descriptive, quantitative, 
qualitative, or participatory.
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Descriptive questions queried frequency of medical check-ups, out-of- 
pocket medical expenses, sick day absences, medication use and consumption 
of dietary supplements. Response frequency percentages were calculated by the 
following formula:
Response % = (Frequency of each response /  total responses within the 
treatment group) *100
Quantitative questions queried participant’s perceptions of how important 
it is to them to make lifestyle changes, readiness to make lifestyle changes, 
confidence in ability to make changes and levels of stress on a scale of zero to 
ten. Lifestyle changes were defined as changes to improve health, such as 
adjusting diet, increasing physical activity, and changing health-related 
behaviors. An example of a scaled-response quantitative question follows:
Put an X on the line to show how ready you are right now, on a scale of 0 to 10, 
to make lifestyle changes. (0 = not very ready, 5 = somewhat ready 10 = very 
ready)
Qualitative questions were open-ended queries that asked subjects what 
lifestyle changes they were willing to make, and what they perceive as barriers to 
making lifestyle changes. For those open-ended responses, general themes 
were identified and assigned a category code. For example, responses to the 
question “What lifestyle changes would you be willing to make?” would be 
assigned to one or more of eight categories: none, consume or manage a 
healthier diet, increase or maintain exercise, both improve/maintain diet and
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improve/maintain exercise, manage weight, stress management, or other. Three 
trained raters read the responses (identity and treatment group were blinded) 
and assigned one or more codes to each. Final determination of categories for 
each response was made when at least two of the three raters had assigned the 
same code to a response. The code assigned by the pre-appointed referee rater 
was recorded in the few instances when a response was not given the same 
code by at least two raters. To determine the measure of agreement among 
raters, the free-marginal kappa (Kfree) was calculated using an online calculator. 
The calculator was specific for use when multiple raters are not restricted in the 
number of codes that are assigned to a singular response. According to 
Randolph, a kappa of .70 or above indicates adequate interrater agreement (51). 
An example of a qualitative question was:
“What things might make it hard for you to make lifestyle changes?”
At 24 months, subjects reported how participation in the WHP impacted 
their lifestyle, health, and how they feel. Responses utilized a Likert-like balanced 
scale. An example of a participatory question follows:
Has participation in the UNH Cooperative Extension Workplace Wellness Study 
impacted your lifestyle? (stayed the same, improved a little, improved somewhat, 
improved a lot, worsened a little, worsened somewhat, worsened a lot).
Because a relatively small number of responses were spread over seven 
options in the participatory questions, sparse entries for some of the response 
cells prevented making a meaningful statistical comparison in that form.
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Therefore, responses were then grouped into three categories for analysis: 1) 
stayed the same, 2) improved or, 3) worsened.
A complete description of results and discussion of the Health 
Questionnaire will be presented in Chapter 3. Please refer to the Appendix for a 
complete version of the Health and Wellness Questionnaire.
Exit Survey. An Exit survey was given at the final health screening at 24 
months. The three-question survey queried changes in lifestyle and health as a 
result of participation in the study and overall satisfaction with the program. An 
example of an Exit question was:
As a result of participating in the UNHCE Workplace Wellness program: What 
lifestyle changes (for example, healthy diet and activity choices, health 
maintenance and stress management) have you made? Please be specific.
The open-ended Exit responses were treated in the same manner as 
described above for qualitative questionnaire responses. A complete description 
of results and discussion of the Exit Survey will be presented in Chapter 3. 
Please refer to the Appendix for a list of the Exit Survey questions.
Calculations
Computation of relative and absolute changes in variables followed the 
calculations of Soler et al., from their 2010 review of the effectiveness of 
Worksite Health Promotions (52):
Absolute change = (lpoSt - lpre) - (Cpost - Cpre)
Relative change = [(lpost/ l pre) /  (Cpost/Cpre) - 1 ] x  100%
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Where I = [mean value for intervention group], C = [mean value for comparison 
group], pre = [baseline measurement], and post = [  12-month measurement].
The cost-effectiveness ratio (C-E ratio) of the intervention was computed by 
dividing the per-capita cost of the intervention by the relative percentage-point 
reduction in LDL-C:
C- E ratio = Cost of intervention / Unit of effectiveness
A complete description of the cost-effectiveness analysis is discussed in Chapter 
2 .
Intervention
The intervention consisted of a wellness education program and the 
distribution of pedometers. The C group did not participate in either component.
Wellness Education Program. The wellness education program was presented to 
I participants using The Granite State Distance Learning Network (GSDLN). 
GSDLN is a partnership of organizations providing an interactive 
videoconferencing network across the state of New Hampshire 
(http://gsdln.org/index.html). UNHCE offices that are subscribers to the network 
have a meeting room equipped with the audio and video technology needed to 
conduct an interactive conference. Each education module was 30 -  35 minutes 
in length and presented by the investigator using PowerPoint® presentation 
graphics software (Microsoft, Inc). Each presentation focused on a different 
health topic such as CVD risk, diabetes, or hypertension and emphasized the
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relationship between a healthy diet and physical activity in disease prevention. 
(Table 1.2).
Participants were encouraged to interact with questions and observations. In 
year one, ten monthly videoconferences were presented. In year two, four 
quarterly videoconferences were presented.
The presentations in year one were accompanied by food samplings 
provided by volunteer facilitators at each site, at the direction of the investigator. 
Foods were chosen for their nutritional benefit and ease of preparation, and also 
to introduce the participants to healthy foods that might be unfamiliar or be 
perceived as unappetizing. Examples included: whole-grain cereal products, 
meatless dishes, reduced-fat dairy products, healthy snack options, and a variety 
of less well-known fruits and vegetables. Participants were encouraged to email 
the primary investigator with any additional questions, suggestions and to offer 
evaluation of the program.
Pedometer Distribution. Intervention subjects were given a new 
pedometer (Digi-Walker™ SW-401, Lees Summit, MO). Participants were 
instructed to wear the pedometers during waking hours, to increase their steps to 
10,000 or more daily and to report their activity totals weekly. Studies suggest 
that 10,000 steps/day is a reasonable level for healthy adults to attain the health 
benefits of regular exercise (53). Alternative activities, such as bicycling, were 
converted to steps using a conversion table provided by the University of New 
Hampshire Center for Health Enhancement. Step counts were reported weekly
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by Intervention participants only, and are presented as average steps per day per 
each thirteen-week quarter of the year.
Statistics
Analyses were based on the assigned treatment at the time of 
randomization, regardless of adherence, and all participants’ data were included 
in the primary analyses. Data from anthropometric, biochemical, clinical, dietary, 
descriptive and quantitative questionnaire responses, and frequency counts of 
questionnaire and exit survey responses were analyzed using general linear 
model (GLM) ANOVA for repeated measures. Anthropometric, biochemical, 
clinical and dietary data were corrected for age and gender, with exception of 
percent predicted pulmonary tests. A self-reported diagnosis of asthma and/or 
the use of bronchodilators were entered as covariates in the GLM model for 
pulmonary tests. Since values of blood hsCRP were skewed, the data were log- 
transformed for parametric analysis. At 12 months, data from one C group 
participant was identified as being an outlier in the analysis of missed days at 
work for year one. Data for this participant was omitted for that analysis only.
Post-hoc analyses were conducted using Tukey’s Honestly Significant 
Difference test. Pearson’s Chi square analysis was used to examine 
questionnaire descriptive responses, individual categories of qualitative 
responses, and same vs. improved participation questions. Data are presented 
as mean ± SE, unless indicated otherwise. The level of statistical significance 
was set at p < 0.05. Statistical analyses were performed using SYSTAT 12 © 
Copyright 2007, SYSTAT Software, Inc.
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Table 1.2. Topics Included in UNHCE Workplace Health Promotion Educational Sessions
Year 1
Introduction/ Proper footwear
•  Introduction to Workplace Health Promotion
•  Schedule for sessions
•  Choosing the proper exercise shoe for you1
•  Question and answer session
Physical Activity /  Pedometers / Hydration
•  Benefits of regular physical activity
•  Keeping hydrated
•  Why use pedometers
•  Pedometer questions
•  Smart Holiday Choices
•  Question and answer session
•  Snack- green tea
Healthy Living / Healthy Eating / Healthy Body
•  How lifestyle makes a difference
•  Get ready for the holidays
•  Obesity facts and statistics
•  Comorbidities of obesity
•  Energy balance for weight loss
•  The Holidays and Your Health: Alcohol
•  Holidays at the Office
•  Question and answer session
•  Snack -  spiced oranges
Carbohydrates
•  Diet resolutions
•  What is a healthy diet?
•  Carbohydrates ~
•  Simple VS Complex
•  Whole grains/Fiber
•  Low-carbohydrate diets
•  Question and answer session
•  Snack- whole grain crackers, breads with hummus
About Fats -
•  What fats are and why we need them in our body.
•  The good ones, and the not so good ones.
•  Benefits of healthy fats.
•  Easy ways to add healthy fats to your diet!
•  Question and answer session
•  Snack -  low-fat or fat-free cheeses
Protein and Meat Alternatives
•  What are Proteins?
•  Sources of Protein
•  Meat & Meat Alternatives
•  Importance of non-meat sources of proteins
•  Easy ways to add healthy protein to your diet
•  Question and answer session
•  Snack -  meatless chili
Healthy Bones2
•  Implications of osteoporosis
•  Risk factors / Diagnosis
•  Current and future treatment
•  Resistance exercise
•  Question and answer session




•  Prevalence of Stress
•  The body’s reaction to stress
•  Risks of Chronic Stress
•  Connection between stress and sleep
•  Connection between stress and exercise
•  Coping with stress
•  Question and answer session
•  Herbal tea
Fruits, Vegetables and “Functional” Foods
•  Fruits and vegetables reduce disease risk
•  Antioxidants and phytochemicals
•  How much should I eat?
•  “What’s that?” quiz ( novel fruits and vegetables)
•  Tips to Eat More (fruits and vegetables, that is!)
•  Question and answer session
•  Snack- star fruits, Asian pears, rainbow carrots
Year 2
Diabetes and Prediabetes -  Opportunity for 
prevention
•  What is diabetes?
•  Complications of diabetes
•  Prevention of diabetes
•  Lifestyle modification
•  Modifiable risk factors
•  How adiposity contributes to diabetes risk
•  Metabolic syndrome
•  Pre diabetes and the “ticking time bomb”
Heart Disease Risk
•  Resolutions for a healthy year
•  Workplace wellness program goals
•  Be active!
•  Atherosclerosis
•  Function of cholesterol in the body
•  NCEP-III recommendations
•  Dietary fats
•  CVD risk factors
•  Women’s risk
Stress management
•  What is stress?
•  Mind - Body Connection
•  How it works -  stress response
•  Chronic stress
•  Speaking of work...
•  Stress reduction
Maintenance of a healthy lifestyle
•  Why work at health?
•  Preventing the preventable
•  Healthy employees save money, and so do their employers
'Presented by Certified Athletic Trainer, Presented by guest graduate student in Nutritional Sciences 
One-hour sessions were presented using Powerpoint® and delivered simultaneously to all sites using 





No differences in baseline measures were found between groups in age, 
anthropometric and biochemical screening tests or markers of metabolic 
syndrome. (Table 1.3).
At 12 months, LDL-C of the I group had a decrease from baseline and was 
significantly less than that of the C group (110.86 ± 4.4 mg/dl, 126.67 ±4.0 mg/dl
respectively, p = 0.011). TC of the I group decreased significantly from baseline 
at 12 months, and also was less than that found in the C group at 12 months 
(183.4 ± 4.4 mg/dl, 198.6 mg/dl, respectively, p = 0.001 within group, 0.013 
between groups). TC of the C group was not different from baseline at the end of 
one year. No other within-group or between-group differences in, HDL-C,
TC/HDL, TRG, FG or hsCRP were found at 12 months.
At 24 months, hsCRP of the I group was 44% less than that of the C group 
at 24 months (p = 0.027). TC and LDL-C were not statistically different from the 
12 month to 24 month value, either within-group or between-groups; nor were 
any within-group or between-group differences observed in, HDL-C, TC/HDL, 
TRG, or FG.
During year one and year two, fasting lipids and glucose also were 
measured at six-month intervals (months 6 and 18). When analyzed at months 0, 
6, and 12, TC of the I group showed a significant decrease from baseline (205.27 
± 4.4 mg/dl, 188.01 ± 4.7 mg/dl, p = 0.017). No within-group or between-group
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differences in TC were measured in the C group. No within-group or between- 
group differences in other lipids were found. In year two, no differences in lipids 
were seen either within-group or between groups in six-month intervals of 12, 18 
and 24 months.
At six months, FG increased significantly from baseline in both C and I 
groups (increases of 8.9 mg/dl, 7.6 mg/dl, respectively, both p = 0.001 from 
baseline) but, when analysis of FG was repeated adding season as a covariate, 
statistical differences were abolished for year one. In year two, no between 
group or within group differences in FG were found. When season was added as 
a covariate to the year two analysis, a between group difference in FG (C = 89.8 
± 1.8 mg/dl, I = 95.9 ± 1.9 mg/dl, p = 0.038) at eighteen months was observed 
that was not present at either 12 or 24 months.
Waist Circumference. Blood Pressure. Body Composition
At 12 months, there was no change in WC of the I group but, the mean 
WC of the C group increased significantly from baseline, (37.1 ±0.4 vs.38.9 ± 0.4 
in, respectively, p= 0.001). The difference in WC between groups at 12 months 
was not significant. No other within-group or between-group differences in 
weight, BMI, PCTFM, TBWPCT, SBP or DBP were observed at 12 months.
At 24 months, WC of the I group (37.3 in) was significantly less than the C 
group (38.7 in, p = 0.04). No other within-group or between-group differences in 
blood pressure or measures of body composition were observed at 24 months.
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Metabolic Syndrome Markers
The mean number of MetS markers increased in the C group from 
baseline to 12 months (1.44 ±0.1, 1.88 ± 0.1 markers, p = 0.018), a value that 
also was greater than that measured in the I group at 12 months (1.29 ± 0.1 
markers, p = 0.002). No within-group difference was noted in the I group. In year 
two, no within-group changes from the 12 month values of MetS were seen in 
either treatment group, nor were any between-group differences measured at 
either 12 or 24 months. (Table 1.3).
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Table 1.3 Health Screening Measurements
Year 1 Year 2
Variable
Comparison 
Baseline 12 Months 
n = 31 n= 29
Intervention 
Baseline 12 Months 
n = 29 n =26
Comparison 
12 Months 24 months 
n = 29 n = 23
Intervention 
12 Months 24 months 
n = 26 n = 20
Age (years) 48.5 ± 1.8 48.5 ± 1.9 51.7 ±1.9 53.7 ±2.1 48.1 ± 1.9 48.3 ±2.0 53.7 ±2.1 48,3 ± 2.0
Weight (lbs) 180.4 ±8.7 185.5 ±9.0 182.2 ±9.8 181.4 ±10.1 166.8 ± 1.0 168.2 ±1.1 166.7 ±1.1 168.2 ±1.1
Body Mass Index (kgfM2) 28.0 ± 1.4 28.5 ± 1.4 29.2 ±1.5 28.8 ±1.6 28.2 ±0 .3 28.4 ±0.3 28.1 ±0.3 28.4 ±0.3
Waist Circumference (inches) 37.1 ± 0.4 38.9 ±0.4*** 37.1 ±0.4 37.8 ±0.5 38.4 ±0.4 38.7 ±0.4 38.4 ±0.4 38.7 ± 0 .4A
Body Fat % 31.1 ± 1.4 30.3 ±1.5 31.7 ±1.5 31.2± 1.6 32.7 ±0.5 34.5 ± 0.6 32.8 ±0.6 34.5 ±0.6
Body water % 49.5 ± 1.1 50.4 ± 1.1 49.3 ±1.1 49.4 ± 1.2 48.9 ±0.4 47.2 ± 0.4 48.7 ±0.5 47.2 ± 0.4
Systolic Blood Pressure (mm/Hg) 125.6 ±1.5 131.0 ±1.6 125.6 ± 1.7 130.9 ±1.8 131.4 ± 1.5 131.8 ± 1.6 133.0 ± 1.8 131.8 ± 1.6
Diastolic Blood Pressure (mm/Hg) 84.6 ±2.1 82.7 ±2.1 87.8 ±2.2 87.0 ±2.4 80.2 ± 1.0 81.1 ±1.1 81.2 ± 1.3 81.1 ±1.1
Total Cholesterol (mg/dl) 200.1 ±3.7 198.6 ±3.9 201.8 ±4.0 183.4 ± 4.4 *** A 186.9 ±2.6 190.5 ±2.8 186.3 ±3.0 190.5 ±2.8
HDL-C (mg/dl) 54.7 ±3.0 48.1 ± 3.2 53.1 ±3.3 48.2 ±3.5 51.0 ± 1.2 54.4 ± 1.3 50.6 ±1.5 54.4 ± 1.3
Triglycerides (mg/dl) 145.7 ±15.7 153.8 ± 16.3 156.7 ± 16.8 142.8 ±18.2 114.0 ±7.4 98.3 ± 8.0 108.1 ±8.5 98.3 ±8.0
LDL-C (mg/dl) 121.0 ±3.7 126.7 ±4.0 122.3 ±3.9 110.9 ± 4.4 A 116.5 ±2.4 117.1 ±2.9 117.3 ±2.8 117.1 ±2.9
TC/HDL 4.1 ± 0.2 4.4 ± 0.3 4.4 ± 0.3 4.4 ±0.3 4.0 ± 0.09 3.9 ± 1.0 4.1 ±0.1 3.9 ± 1.0
Fasting Glucose (mg/dl) 88.5 ± 1.3 92.0 ± 1.3 90.1 ±1.4 90.6 ± 1.5 91.5 ± 1.5 92.0 ± 1.6 91.9 ± 1.8 92.0 ± 1.6
hsC-Reactive Protein (mg/L) 2.2 ±0.3 2.8 ±0.3 2.2 ±0.3 2.9 ±0.3 2.6 ± 0.4 2.9 ±0.5 2.6 ±0.5 2.9 ± 0.5 A
Metabolic Syndrome Markers 1.4 ±0.1 1.9 ± 0 .1 * 1.5 ±0.1 1.3 ±0.1 AA 1.8 ±0.2 1.8± 0.2 1.3 ±0.3 1.8± 0.2
* p s  0.05 within group, ** p s  0.01 within group, " *  p s  0.001 within group,A p s  0.05between groups,AA p s  0.01 between groups,AAA p £ 0.001 between groups
All variables except age and Metabolic Syndrome Markers corrected fa  age and sex. Statistical analyses were perfamed by general linear model using SYSTAT 12.
Post hoc analysis was performed using Tuke/s Honestiy-Significant-Difference Test. Statistical significance was set at p ^  .05
Pulmonary Function Studies
Baseline values for the percent predicted value of FEVi (^opredFEV!) and 
the percent predicted value of PEF (%preciPEF) were not different between 
groups. No differences were found between or within groups at 12 months in 
either %predFEVi or %predPEF. At 24 months, the mean self-reported %predFEVi 
in the I group was greater than that of the C group (99.1 ± 2.2%, 88.8 ± 2.6 %, p 
= 0.024), and the mean self-reported %predPEF was not different between groups. 
No within-group differences were found in either self-reported %predFEVi or 
%PredPEF at 24 months. No differences between groups or within groups were 
noted in diurnal variation in FEN  ^at 12 or 24 months.
At the study exit, the researcher-observed % predPEF of the C group was 
lower than in the I group, but, was not significantly different (73.2 ± 6.1%, 81.5 ± 
5.3% . p = 0.1). The researcher-observed %predFEV1 was not different between 
groups. The self reported pulmonary values of the combined cohorts (all 
participants) were correlated to those measured by the researcher at study exit.. 
(Table 1.4). Complete pulmonary function test results can be found in the 
Appendix.
Correlations among clinical findings
During years one and two, WC correlated significantly with hsCRP, r =
0.56 ( year one); r = 0.50 ( year two) p < 0.001. In year one, hsCRP also was 
found to correlate with LDL-C r = 0.31 p = 0.004 and WC correlated negatively 
with HDL-C, r = -0.33. p = < 0.001.
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Table 1.4 Correlation of Self-reported with Researcher-observed Exit Pulmonary
Function Tests
Variable pairs r P
FEV1 Self- reported FEV1 Exit 
PEF Self- reported PEF Exit 
% PRED FEV1 Self- reported % PRED FEV1 Exit 





FEV1 -  forced expiratory volume in 1 second, PEF -  Peak expiratory flow rate
% PRED FEV1, % PRED PEF - Test values were compared to predicted normal values for PEF (49) and FEVi 
(50); Percent of predicted = (measured PEF or FEVi ) /  (predicted PEF or FEVi) * 10 
Self-reported = test values reported by participants at 24 months, Exit = values of investigator-observed tests at 
study exit.
Statistical significance was set at p < 0.05 
Diet Analysis
Baseline, 12 and 24 month analyses. At baseline, the percent of 
unspecified dietary fats consumed was significantly greater in the I group than 
the C group (9.4%, 7.0%, p = 0.02). No other between-group differences in 
nutrient consumption were noted.
At 12 months, the n-6/n-3 ratio of the C group was found to be greater 
than that of the I group (14.49 ±1.8; 10.33 ±2.3, p = 0.03). (Figure 1.2 ). There 
were no other differences found between groups in any nutrient. No significant 
differences in nutrient intakes were found in the 24 month diet analysis. However, 
at 24 months, n-6 fatty acids consumption of C group tended to be higher than I 
group (p = 0.09).
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Figure 1.2 Between-group Difference in Ratio of Omega-6 to Omega-3 Fatty Acids




■  C om p arison  
*  In te rv e n tio n
Com parison In te rv e n tio n A p < 0.05 
between groups12 Months
Difference between Comparison and Intervention groups at 12 months. Analyses were performed by General 
Linear Model and corrected for age and gender. Statistical significance was set at p < 0.05.
Analyses bv year. In year one, energy intake from baseline decreased in the C 
group (1893.4 ± 68.6 kcals; 1629.06 ±84.9 kcals, p = 0.019) and the I group 
(1881.7 ±89.1 kcals, 1485.05 ± 110.5 kcals, p = 0.001) The I group also reported 
a decrease in percent of unspecified dietary fats from baseline levels (8.0% ± 
0.6% to 5.96% ± 0.8%, p = 0.033) (Figure 1.3), as well as grams of 
carbohydrates (249.38 ± 13.4 gms to 196.19 ± 16.8 gms, p = 0.006), and iron 
(16.21 ±1.1 mg to 11.94 ± 1.4 mg. p = 0.01), data are presented in the Appendix. 
No other within-group differences were noted; and no between group differences 
were found in any nutrient in year one. In Year two, there were no within-group or 
between group differences found in any nutrient from 12 to 24 months.
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■  C om p arison




12 months *p < 0.05 
within group
Between-group and within-group differences at baseline and 12 months. Analyses were performed by General Linear 
Model and corrected for age and gender. Statistical significance was set at p < 0.05.
In the subset of diet records analyzed for MyPyramid food groups 
servings, a decrease in the percent of recommended grain consumption from 
baseline levels was reported in the I group (99.77% ± 16.4%, 53.82% ± 16.6%, p 
= 0.039). No other within-group differences were noted in either group and no 
between-group differences were found for any food group.
Dietary changes and clinical measurements correlations. Multiple 
regression analyses were used to determine which, if any, of the anthropometric 
and dietary changes observed during the intervention year one could explain the 
changes in LDL-C from baseline in the I group. It was found that two factors, 
dietary n-6/n-3 fatty acids and changes in percent body fat explained 41% of the 
variance in the change in LDL-C (R2 = 0.41 , f (2,25) = 8.58, p = 0.001). For
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dietary n-6/n-3 ratio, intake correlated inversely; i.e., the greater the reduction in 
the ratio of n-6 to n-3 fatty acids, the greater the improvement in LDL-C 
concentration in year one (r = -0.51, p = 0.003). For PCTFM, the correlation was 
positive ( r = 0.42, p = 0.011) with the change in LDL-C. (Figures 1.4A and 
1.4B). Furthermore, in year one, grams of dietary n-6 fatty acids positively 
correlated with grams of dietary saturated fatty acids ( r = 0.42, p = 0.024) and 
grams of dietary fiber consumption correlated negatively with WC ( r = -0.29, p = 
0.03). Complete Diet Analyses results can be found in Tables 1.5 and 1.6.
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Figure 1.4 Correlations of Year One Change in LDL-C and Dietary and Anthropometric Variables
A. Correlation of Year One Dietary Omega Fatty Acid Ratio 
with the Change in LDL-C
B. Correlation of the Year One Change in Body Fat Mass 
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Fig. 1. 3A Dietary n-6/n-3 ratio, intake correlated inversely: i.e.. the greater the reduction in the ratio of n-6 to n-3 fatty acids, the greater the improvement in 
LDL-C concentration in year one (r = -0.51. p = 0.003). Figure 1. 3B Decrease in percentbody fat correlated positively with the change in LDL-C (r = 0.42. p 
= 0 .011). Statistical significance was setatp £ 0.05.
Table 1.5 Year 1 Diet Analysis
Variable Comparison Intervention
Baseline 12 months Baseline 12 months
CVJC\JIIc (n =18) (n = 21) (n = 13)
Carbohydrate (%  of kcals) 48.2 ± 2.1 49.1 ± 2.4 49.1 ± 2.6 50.2 ± 2.9
Protein (%  of kcals) 16.3 ± 1.3 17.7 ± 1.4 16.5± 1.6 16.6 ± 1.8
Fat (%  of kcals) 34.2 ± 1.8 33.3 ± 2.0 34.3 ±2.2 32.4 ± 2.5
Saturated fat ( % of kcals) 11.5 ± 0.8 11.0 ± 1.0 10.5± 1.0 10.5 ± 1.2
Monounsaturated fat (%  of kcals) 9.5 ± 2.0 13.0 ± 2.3 8.7 ±2.4 8.7 ± 2.8
Polyunsaturated fat (%  of kcals) 5.6 ± 0.5 6.4 ± 0.6 5.3 ± 0.7 5.9 ± 0.8
Unspecified fats (%  of kcals) 7.1 ± 0.5 6.6 ± 0.6 8.0 ± 0.6 6.0 ± 0.8*
Energy (kcals) 1893.4 ± 68.6 1629.1 ± 84.9* 1881.7 ± 89.1 1485.0 ± 110.5***
CHO (gms) 247.6 ± 10.5 221.8 ± 12.9 249.4 ± 13.4 196.2 ± 16.8**
Fat (gms) 74.8 ± 6.8 76.0 ± 7.7 79.2 ± 8.4 68.8 ± 9.5
Protein (gms) 78.2 ± 3.3 68.4 ± 4.0 78.1 ±4.3 66.7 ± 5.2
Saturated fat (gms) 28.0 ± 2.4 26.5 ± 2.7 27.7 ± 2.9 26.1 ± 3.3
Monounsaturated fat (gms) 26.0 ± 2.2 22.8 ± 2 .5 24.6 ± 2.7 20.5 ± 3 .0
Polyunsaturated fat (gms) 13.1 ± 1.3 14.4 ± 1.4 13.9 ±1.6 13.2 ± 1.8
Cholesterol (mg) 316.0 ±30.6 299.6 ± 35.0 314.7 ±38.1 344.1 ± 43.2
Omega-6 fatty acids (gms) 9.0 ± 1.0 10.5 ± 1.2 9.6 ± 1.3 8.9 ± 1.5
Omega-3 fatty acids (gms) 0.7 ±0 .2 0.8 ± 0.2 0.9 ± 0.2 0.7 ± 0.3
Omega-6 / Omega-3 ratio (n) 14.4 ± 1.4 15.3 ± 1.6 13.6 ± 1.7 12.0 ± 1.9
Fiber (gms) 24.5 ± .41 23.5 ± 1.7 25.2 ± 1.7 20.1 ± 2.1
Sugar (gms) 95.5 ± 6.4 83.6 ± 7.8 95.4 ±8.0 84.7 ± 9.9
CA (gms) 817.4 ± 93.3 726.6 ± 106.6 730.1 ±116.0 611.6 ± 131.3
FE (gms) 16.0 ± 0.9 15.1 ± 1.1 16.2 ± 1.1 11.9 ± 1.4**
Mg (gms) 282.9 ± 24.3 263.1 ± 27.7 267.5 ± 30.2 274.1 ± 34.2
K (gms) 2579.6 ± 182.0 2495.6 ± 207.9 2690.6 ±226.4 2755.3 ± 256.2
Zn (gms) 10.5 ± 1.0 9.5 ± 1.1 9.2 ± 1.2 9.6 ± 1.4
NA (gms) 3072.8 ± 196.3 3172.3 ±224.3 3136.0 ± 244.3 2824.0 ± 276.4
* p < 0.05 within group, ** p < 0.01 within group, *** p < 0.001 within group
Diet analysis was performed using Diet Analysis Plus 8.0 using 3-day self-reported diet record. All variables corrected 
for age and sex. Statistical analyses were performed by general linear model using SYSTAT 12. Post hoc analysis was 
performed using Tukey's Honestly-Significant-Difference Test. Statistical significance was set at p < .05
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Table 1.6 Year 2 Diet Analysis
Variable Comparison Intervention
12 months 24 months 12 months 24 months
(n = 18) (n = 17)
COitc 3* n -2
Carbohydrate (%  of kcals) 50.0 ± 2.1 50.7 ±2.1 51.4 ±2.6 53.2 ± 2.5
Protein ( % of kcals) 17.7 ± 1.5 16.1 ± 1.5 16.5 ± 1.9 14.9 ± 1.8
Fat ( %of kcals) 31.6 ±2.1 32.2 ± 2.2 30.2 ±2.6 31.0 ± 2.5
Saturated fat (%  of kcals) 10.7 ± 0.9 10.6 ± 0.9 10.2 ± 1.2 10.2 ± 1.1
Monounsaturated fat (%  of kcals) 12.7 ± 3.0 7.5 ± 3.0 7.1 ± 3.5 7.6 ± 3 .3
Polyunsaturated fat (%  of kcals) 6.1 ± 0.7 5.3 ± 0.7 5.5 ± 0.9 4.6 ± 0.8
Unspecified fats ( % of kcals) 7.1 ± 1.1 8.5 ± 1.1 7.4 ±1.4 7.7 ± 1.3
Energy (kcals) 1888.5 ± 134.1 1971.6 ± 135.3 1865.7 ± 165.5 1829.1 ± 155.7
CHO (gms) 238.8 ± 18.3 257.5 ± 18.5 248.1 ± 22.6 249.4 ±21.3
Fat (gms) 71.3 ±7 .3 72.8 ± 7.4 64.0 ±9.1 63.2 ± 8.5
Protein (gms) 77.0 ± 5.8 79.4 ± 5.9 78.6 ± 7.2 70.5 ± 6.8
Saturated fat (gms) 23.3 ± 2.9 23.6 ± 2.9 21.9 ± 3.6 20.6 ± 3.4
Monounsaturated fat (gms) 14.6 ±2 .7 14.8 ± 2 .7 12.6 ±3.2 13.2 ± 3 .0
Polyunsaturated fat (gms) 13.1 ± 1.5 11.8 ± 1.6 11.3 ± 1.9 10.0 ± 1.8
Cholesterol (mg) 257.3 ± 33.0 220.7 ± 33.3 277.6 ± 40.7 230. 9 ± 38.3
Omega-6 fatty acids (gms) 9.6 ± 1.3 8.1 ± 1.3 7.7 ± 1.6 6.8 ± 1.5
Omega-3 fatty acids (gms) 0.8 ± 0.3 0.6 ± 0.3 0.6 ± 0.3 0.5 ± 0.3
Omega-6 / Omega-3 ratio (n) 15.0 ±2.1 15.5 ± 2.2 11.6 ± 2.6 14.8 ± 2.4
Fiber (gms) 20.5 ± 5.4 27.9 ± 5.4 20.3 ± 6.7 16.4 ± 6 .3
Sugar (gms) 87.3 ± 9.8 98.5 ± 10.0 94.3 ±  12.7 93.0 ±  11.7
CA (gms) 675.2 ±  153.1 964.3 ±  155.1 632.4 ±189.6 688.3 ±  177.3
FE (gms) 13.6 ±2 .2 15.2 ± 2 .2 15.1 ±2.7 14.1 ±  2.5
Mg (gms) 254.4 ± 26.9 257.0 ±27.1 263.9 ±33.2 224.2 ±31.2
K (gms) 2498.4 ±  185.9 2573.0 ±  188.7 2627.8 ±  237.4 2394 .5 ±217.4
Zn (gms) 8.6 ± 1.6 9.4 ±  1.7 8.8 ±  2.0 7.0 ±  1.9
NA (gms) 2795.2 ±  254.0 2847.6 ±  247.5 2308.5 ±334.5 2489.3 ±  302.3
Diet analysis was performed using Diet Analysis Plus 8.0 using 3-day self-reported diet record .All variables corrected 
for age and sex. Statistical analyses were performed by general linear model using SYSTAT 12. Post hoc analysis 
was performed using Tukey's Honestly-Significant-Difference Test.. All variables NS between or within groups. 
Statistical significance was set at p < .05
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Intervention Step Counts
Only female participants reported steps. Twenty participants reported baseline 
values. At the end of year one, the number of participants in the I group that 
reported steps was fourteen (54% of I group). A separate analysis at baseline 
and at each quarter found no significant differences in the mean number of steps 
of those participants who reported steps for all four quarters, and those that did 
not
During year one, average steps per day increased significantly from baseline 
(5253 ± 368 steps/day) by the second quarter, and continued at that level for the 
duration of the year (7149 ± 400 steps/day, p = 0.01). (Figure 1.5). At the end of 
year two, the number of reporting participants dropped to four. During year two, 
the average steps per day remained unchanged from the end of year one (7010 
± 367 steps/day). Complete Intervention step data can be found in the Appendix.





5000 - * p < 0.05 from  baseline
4000
Quarter 3 Quarter 4Baseline Quarter 1 Quarter 2
Wiithin-group differences in steps/day at baseline and each quarter-year during year 1. Analyses were performed by 
General Linear Model and corrected for age.Data re presented as LSM ± SE. Only female participants reported steps. 
Statistical significance was set at p < 0.05.
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Discussion
Findings of the present study show that a WW program of monthly 
education sessions was effective in producing a decrease in TC and LDL-C in 
the I participants and preventing the increase in WC and MetS markers seen in 
the C participants in year one. Moreover, the quarterly education sessions in year 
two were sufficient to sustain the improvements in lipids seen in year one and 
promote additionally identified decreases in hsCRP and WC in the I group.
Lipid improvements
Having a high level of LDL-C is a major risk factor for CVD and the 
decrease of 8% in TC and 13% in LDL-C (from baseline and relative to the C 
group) found in the I participants of the present study suggests a reduction in 
CVD risk. Lifestyle modifications that include adjustment of dietary fat intake, 
increased physical activity and weight control can decrease LDL-C by up to 
30%(13). Our finding of reduced LDL-C is consistent with previous investigations 
of lifestyle change that reported LDL-C reductions of 5% - 28% (54-56).
On the other hand, our results are in contrast to those referenced in a 
recent review by Groeneveld, et al. (57). In some cases of earlier worksite 
investigations, it was noted that either total or LDL cholesterol was not different 
from controls following an educational intervention. The educational interventions 
reviewed were aimed at improving lifestyle behaviors, although differed from 
each other and the present study in length of intervention; 12 weeks (58), 6 
months (59), and 12 months (60). The study design in all of the aforementioned
37
studies, were somewhat similar to ours in that the interventions included 
enhanced educational components in addition to the screening with minimal 
information received by all study participants. However, the educational 
components varied widely in that they consisted of private counseling (61), four 
group sessions (59), or monthly individual sessions along with group classes 
(60). Additionally, two of the study populations were limited to individuals with 
elevated cholesterol levels (59, 60), and one to individuals diagnosed with angina 
(58). The differences in findings of the present study from those cited may have 
occurred due to the frequency, duration, style, or content of the interactive 
educational sessions. However, it is possible that the improvement seen among 
the I group in our study in total and LDL cholesterol might also be partially 
attributed to the health status of the study population. The subjects of the current 
study were not recruited or screened for the presence or absence of CVD risk 
factors, and were considered in relatively good health. This supports the 
interpretation that a WHP that promotes healthy lifestyle practices is a 
preventative effort that can help to preclude the hazard of modifiable disease 
among employees without previously identified risk factors.
Waist Circumference and Metabolic Syndrome Markers
Waist circumference is a surrogate measure of abdominal fat mass, and is 
independently associated with cardiometabolic disorders (62, 63). It is now 
understood that abdominal fat mass as measured by WC is a more significant 
risk factor for CVD than total adiposity, per se (64). Although the percentage total 
body fat mass was not found to be different between or within groups in the
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present study, WC in the C group increased significantly in year one, and was 
larger yet at 24 months. In contrast, a non-significant decrease in WC of the I 
group resulted in a significant difference from the C group at 24 months.
We did not observe any statistical changes or differences in BMI or total 
fat mass either within or between groups. However, we did find that change in fat 
mass positively correlated with change in LDL-C at 12 months. In an 
international, cross sectional study of 69,409 men and 98,750 women, Balkau et 
al. found that there was a graded increase in the frequency of CVD with both BMI 
and WC, with a stronger relationship for WC than for BMI in both genders (65).
In the present study, the number of MetS markers in the I group remained 
unchanged from baseline to 24 months. This was in contrast to the C group, 
where the number of MetS markers increased in year one; were greater than in 
the I group, and remained elevated during year two. This is consistent with the 
findings of another study of a 12 month lifestyle intervention in dysmetabolic 
individuals that showed an increase in MetS components in the control group. Bo 
and Ciccone reported that metabolic deterioration in the intervention group of 
their study was prevented, in part, due to a decreasing WC and BMI (66). That 
study differs from ours in that the subjects received individually- prescribed diet 
and exercise recommendations. We also did not identify a decrease in BMI in our 
I group. However, sample size and insufficient statistical power could account for 
the dissimilarity in findings. The decrease of 0.29 Kg/M2 in the BMI of the 169 
intervention subjects in the aforementioned study was sufficient to be statistically
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significant, while a decrease of 0.38 Kg/M2 in the BMI of the 26 intervention 
group subjects in the present study was not.
The prevalence of MetS in adults is increasing and there is an abundance 
of evidence that individuals with MetS double their risk of CVD (6). In cross- 
sectional investigations of both a general population and a cohort at-risk for 
diabetes, the prevalence of the MetS increased with increasing age among 
women (67). Epidemiological research has shown that CVD mortality risk nearly 
doubles in those with even 1 or 2 MetS markers compared to those who have 
none (68).
The presence of MetS markers can indicate a general decline in wellness, 
or pre-disease, among employees. In a worksite study of over 5,000 employees, 
it was found that as the number of risk factors increased, there was an increase 
in absenteeism and illness days (69). In 2009, Schultz and Edington reported, 
that during the two-year span of their risk appraisal study of approximately 3300 
manufacturing workers the prevalence of MetS increased. They also found that 
those employees with MetS were more likely to report new cases of heart 
disease, diabetes and other chronic diseases (70).
The impact of the intervention treatment on WC and MetS markers of the 
present two year investigation is noteworthy considering that the participants 




It is now recognized that inflammation is an important etiological element 
in MetS and CVD risk (71). In the present investigation, we found that hsCRP 
was reduced in the I group at 24 months from 12 months and less than that seen 
in the C group. In addition, WC and LDL-C were both positively correlated with 
hsCRP in our entire study cohort. This association is similar to the results of a 
cross-sectional study in men that investigated the relationship of hsCRP levels of 
a low or moderate range and determinants of MetS (72). That study showed a 
significant positive correlation between hsCRP, BMI and LDL-cholesterol among 
other indicators of MetS. A positive correlation between WC, markers of 
inflammation, as well as insulin resistance has been found in women with MetS 
(32). These findings suggest that a variety of components of the MetS are 
associated with elevated hsCRP levels in both genders.
The crucial mediators of metabolic syndrome and obesity-related 
inflammation have been identified as a complex set of chemical messengers that 
reside in the abdominal depot of total adipose tissue (73). Recent investigations 
have provided evidence that a reduction in markers of inflammation and insulin 
resistance occurs following weight loss. A review of 33 weight-loss intervention 
studies that reported measuring CRP found that, in all studies, weight loss was 
linked in a linear fashion decline in CRP level (74). In a separate study, CRP was 
decreased and insulin sensitivity improved following weight loss and a reduced 
waist-to-hip ratio in 60 obese women over two years (75).
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Pulmonary Function Tests
Reduced pulmonary function has been associated with increased body fat 
mass, cardiovascular disease; and it has been shown to predict the development 
of insulin resistance (45, 76, 77). Interestingly, increased WC (a risk factor of 
insulin resistance) and not BMI, has been found to be negatively associated with 
pulmonary function in normal weight, overweight and obese subjects (46). Given 
these links, our study sought to identify a relationship between indices of 
abdominal obesity and pulmonary function. In the present investigation we did 
not observe a significant relationship between WC or the markers of MetS and 
pulmonary function.
However, it was noted at 24 months that the self-reported percent of 
predicted FEVi was greater in the I than in the C group. The test means of both 
groups at that time were above the specified cut-off predicted value (80%) 
thereby indicating normal pulmonary function in both cases (78). The results of 
the observed testing performed by the study investigator during the Exit testing 
were somewhat different, but correlated closely to those that were self-reported 
by the participants at 24 months. Investigator observed testing of 91% of all 
participants at the end of the study resulted in measures similar to those of the 
self-reported tests, but were not significantly different between groups.
In a randomized sample of 2,153 men and women aged 35 -  79 years, it 
was found that the percent predicted FEVi was inversely associated with WC in 
both men and women (79). It should be noted that in the above study, the 
relatively small differences in percent predicted FEVi were found across four
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quartiles of WC, for both men and women. Our return rate of airway test 
measurements from participants was poor at 12 and 24 months (15% and 40%, 
respectively). It is likely that the number of reports at 12 months, coupled with a 
small subject pool, did not provide enough statistical power to identify 
differences, trends, or associations, if present.
Dietary pattern link to inflammation
Dietary changes that occurred in the I group of the current investigation 
indicated a modification in fat intake that is associated with reduced CVD risk and 
inflammation. At the end of year one, the I group reported a decrease in intake of 
fats that were categorized by the diet analysis software to include trans fats. In 
addition, the intake of dietary n-6 to n-3 fatty acid ratio was less in the I group 
than the C group, and the n-6 to n-3 ratio was a significant predictor of the 
decrease in LDL-C that occurred in year one. Further analysis showed that 
intake of n-6 fatty acid intake was correlated directly with saturated fat 
consumption. At 24 months, intake of n-6 fatty acids was greater among C than I 
group. In year two, hsCRP was found to significantly increase within C group and 
WC was found to be greater than I group at 24 months.
According to the American Heart Association Nutrition Committee, multiple 
dietary factors influence CVD risk, but, the most influential factors in LDL-C 
concentrations are saturated and trans fatty acid intakes (80). In a clinical trial of 
varying levels of trans fat consumption, the diet with the lowest concentration of 
trans fat was associated with a reduced LDL-C of 12% (81), a result that is 
consistent with the 13% relative reduction in LDL-C seen in the present study.
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We did not measure any differences in the consumption of saturated fats. 
However in year one, the correlation of dietary n-6 fatty acids with saturated fat 
intake in our study suggests higher a consumption of saturated fats in 
participants who also consumed higher amounts of n-6 fatty acids. This finding 
could infer that the C group intake of saturated fats was, on the whole, higher 
than of the I group due to their higher n-6 to n-3 fatty acid ratio at 12 months and 
a higher n-6 fatty acid intake at 24 months.
In addition to the negative impact that trans fatty acids have on LDL-C
concentrations, there is evidence that they are also linked to inflammation. In a
cross-sectional examination of data from relatively healthy women from the
Nurse’s Healthy Study cohort, it was found that CRP levels were 73% higher
among those that had the highest trans fatty acid intake (82). On the other hand,
dietary strategies that include n-3 fatty acids, reduced trans and saturated fats
are associated with reduced inflammation (83).
*
The ratio of dietary n-6 to n-3 fatty acid intake also is linked to 
inflammation. A recent review suggests that the two families of polyunsaturated 
fatty acids (PUFAs) appear to have reciprocal effects on inflammation; n-3 fatty 
acids being anti-inflammatory, while n-6 fatty acids are proinflammatory (83). 
Consistent with the results of the present investigation, Guebre-Egziabher, et al. 
found that a reduced n-6 to n-3 ratio achieved with simple dietary counseling, 
was sufficient to attain significant reductions in LDL-C and inflammatory proteins 
(84). Similarly, a 2 year clinical trial of otherwise healthy obese women who
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reduced dietary energy, saturated fat, and had a lower ratio of n-6 to n-3 fatty 
acids than control subjects, reduced CRP (75).
The physiological response to dietary changes intended to reduce 
inflammation may differ based on the degree of adiposity. A cross-sectional study 
of overweight and lean subjects found that dietary n-3 fatty acids were correlated 
negatively with CRP; and n-6 fatty acids were correlated negatively with another 
inflammatory marker, 11-6, but only in the overweight group (85). These findings 
are somewhat different with those of another study of a non-overweight 
population that reported an inverse association of both plasma n-6 and n-3 fatty 
acids with both CRP and IL-6, but a strong positive relationship to both markers 
with the ratio of n-6 to n-3 fatty acids (86). The results of the present investigation 
suggest that the metabolic profile of the C group (CRP and WC greater than that 
of the I group) was associated with a higher consumption of n-6 to n-3 fatty acid 
ratio than the I group.
Physical Activity
Reductions in cholesterol (87), components of MetS (88), adiposity (89), 
and CRP (90) have been linked to physical activity by using pedometer- 
determined walking. Gregg,et al. found that diabetics who walked at least 2 hours 
per week had reduced CVD mortality rate by 34 percent compared with inactive 
individuals (91) In addition, multiple studies report that there is a linear 
relationship in observed changes in clinical variables such as BMI, WC, 
components of MetS (92, 93) and body fat (88) to the number of steps walked 
daily. At 12 months, the I participants reported a mean of 6878 ± 456 steps/day,
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although, they were encouraged to walk 10,000 steps/day. Alternatively, it was 
strongly suggested that they increase their daily step count from baseline or 
participate in other regular, aerobic activity. According to Tudor-Locke and 
Bassett, while 10,000 steps/day appears to be a reasonable estimate of daily 
activity for apparently healthy adults, health benefits of activity and its 
sustainability may be more related to incremental improvements relative to 
baseline values (53). Step data for year one in the present study indicated that 
50% of the I group increased daily step counts significantly by 30% daily 
compared to baseline; and maintained that activity level during year one.
The present findings are similar to the mean increase of 2183 steps/day 
reported in a 2007 review of 18 observational studies (mean duration 18 weeks) 
of pedometer use, physical activity and health outcomes (94). Since the overall 
mean improvement in pedometer-measured physical activity in that review 
increased by 26.9%, our results are, at least, comparable.
It is noteworthy that the mean steps/day did not decrease from 12 to 24 
months. However, there was a reduction in the reporting of steps/day to 20% of 
the I group over the span of 24 months. However, this is not inconsistent with 
other observations. Pettman et al, compared their attrition and reporting statistics 
to other lifestyle interventions. They found that the expected adherence to 
exercise would be, on average, 50% (95). Hence, the compliance rate of 50% in 
the first year of our study appears to be acceptable. Interestingly, 69% of the I 
group reported step data for at least 13 weeks. Our compliance rate was similar 
to that of another study whose authors maintain that interventions of duration
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longer than four months tend to have greater attrition. In their study, the 69% 
attendance at exercise sessions achieved at four months was reduced to 50% 
after the fourth month (96).
Limitations and Strengths
Limitations of this study include the reliance on self-reported information 
for diet, physical activity and pulmonary function. It is not likely that the 
decreased energy intake reported by our study participants accurately reflected 
their usual consumption, since there was no corresponding decrease in body 
weight found. Underreporting of energy intakes in diet records is common, even 
when the subjects or clients have been educated in how to estimate portion sizes 
and to include all food and beverages (96-98). Although misreporting may have 
occurred in both the C and I groups, the differences found in fat consumption 
were expressed in ratios and percentage of total intake, rather than absolute 
amounts of nutrients. Therefore true accuracy of intake would have been affected 
less due to underreporting. In another worksite intervention study designed to 
reduce the risk of CVD, the authors concluded that since the misreporting of 
dietary information occurred in both groups that bias was not introduced (99).
It is possible to detect misreporting of energy intake in weight-stable 
individuals by the estimation of resting energy expenditure of the individual or 
empirically by using a laboratory method such as doubly labeled water (100). 
Such a method should be considered in future studies. It is also possible that 
there were associations between dietary factors and clinical measurements that 
were missed due to a loss of statistical power. At 12 months, there was a return
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of only 56% of diet records while baseline and 24 month diet records were 
returned at a rate of 72% and 81 %, respectively. However, other studies have 
reported diet record return rates as low as 33% (95). Taken together, we would 
argue that underreporting did not diminish the impact of the relationships we 
have described herein between dietary factors and clinical measurements.
The burden of reporting physical activity over such a long period of time 
(i.e. 24 months) may have only reduced compliance with self-reporting, rather 
than reduced physical activity, per se. Support for this possible interpretation is 
suggested from results of responses to the Exit Survey in which the study 
participants reported that more of the I group than the C group increased 
physical activity (data in Chapter 3), and the sustained clinical improvements 
measured in the I group over 24 months.
The usefulness of a hand-held spirometer to detect changes in relatively 
healthy individuals may also be limited due to respondent burden. This 
assumption is in accordance with the findings of others who report high 
withdrawal rates, falsified values and poor adherence in investigations of the 
accuracy of self-monitoring PEF measurements (101-103). Moreover, a known 
limitation to pulmonary function is that many asthmatics have normal tests 
between episodes (104).
It is possible that medication use in the few participants with diagnosed 
asthma (4 at baseline, 3 at 24 months) confounded our results. However, both 
the self-reported diagnosis and reported use of medications were entered into 
the statistical model as covariates to account for their affect. Furthermore,
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instructions for the measurements included the qualification that testing be 
conducted during a week without a cold or other respiratory ailment. It is possible 
that the use of a self-recording spirometer might reduce participant burden and 
provide better compliance in any future investigation.
It is possible that self-selection bias among participants occurred, since 
individuals who were more motivated to make lifestyle changes may have been 
more likely to volunteer. Also, our experimental design did not include a true 
randomized control group. C group participants were exposed in the workplace to 
the I group participants and could have emulated physical activities or dietary 
patterns learned by observation.
Because all participants received their test results and newsletters, 
undesirable results may have prompted private interventions outside of the 
research protocol, such as clinic visits and external health or fitness programs. It 
was beyond the scope of the study to control for outside influences that would 
modify behaviors. Another limitation of this study was that the sample size was 
small; however, participation rate was 35% of employees.
A strength of our study was the implementation of videoconferencing to 
deliver simultaneous educational videoconferences, in different worksites of a 
decentralized organization. Moreover, access to the videoconferences could be 
broadened. For example, educational sessions might be viewed on personal 
desktop computers at work, as the most up-to-date software allows for remote 
internet viewing and archiving for later viewing. The use of technology can help 
to ease concerns about high costs and accessibility.
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Because a small organization limits the potential pool of participants, our 
study protocol did not exclude any volunteers according to the presence or 
absence of preexisting risk factors. Analysis of baseline characteristics, however, 
showed the population to be relatively healthy with no differences between 
groups in measures of CHD risk. It could be argued that the impact of our results 
is increased and could be generalized to a typical employee population.
Summary /  Conclusions
As a result of participation in a WHP, the I group achieved a reduction in 
total and LDL cholesterol, thereby reducing risk for cardiometabolic disease in 
year one. During that year, an increase in WC and MetS markers occurred in the 
C group and was avoided in the I group.
Dietary results in year one reinforce the conclusion that the I group 
modified diet in a healthful manner by decreasing total and unspecified (primarily 
trans) fats as well as consuming a ratio of omega-6 to omega-3 fatty acids that 
was less than that of the C group. This is a beneficial outcome because both the 
amount and class of dietary fats can influence the metabolic profile.
The assertion that a favorable impact on lifestyle occurred is supported by 
the increased step activity, increased exercise, improved diet and lifestyle 
reported by the I group. The I group subjects reported making more lifestyle and 
health changes overall relative to the C group.
Changes that occurred in year one of the WHP were sustained during 
year two, a period of less frequent educational sessions. Intervention education
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that persisted throughout year two may have reinforced the need for healthy 
changes, or identified new changes that needed to be made since educational 
material varied from year one to year two. In addition, differences in WC and 
CRP that occurred at 24 months between groups may reflect that additional, 
small changes occurred over time and contributed to the prevention of changes 
that occur with aging.
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CHAPTER 2: COST-EFFECTIVENESS OF A WORKSITE HEALTH
PROMOTION AMONG EMPLOYEES OF UNIVERSITY OF NEW HAMPSHIRE 
COOPERATIVE EXTENSION 
Introduction
Chronic diseases are leading causes of death and increasing in 
prevalence. These conditions are linked to modern lifestyle (1); however, lifestyle 
modifications can avert these disorders (2). These conditions are predictable if 
risk factors are indentified; therefore, they are also preventable (3).
Elevated blood low-density lipoprotein cholesterol (LDL-C) is a risk factor 
that is associated with coronary heart disease (CHD), frequently coexists with 
metabolic syndrome (MetS) and is the principal target for CHD risk reduction (3). 
Studies indicate that there is a reduction in CHD risk of at least 1% for every 1% 
reduction in LDL-C (4-6).
Investigators have maintained and shown that worksites are uniquely 
positioned to provide health promotion that successfully reduces risk for the 
development of chronic disease in employees (7-9). Employers are concerned 
about financial outlay for health costs that include medical plan contributions, sick 
leave, disability and worker’s compensation costs (10). Employees with 
modifiable lifestyle risk factors cost employers 228% more in health costs than
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risk-free employees (11). However, costs and absenteeism are decreased when 
employee’s heath risks are reduced through worksite programs (12). A meta­
analysis of studies on cost-savings associated with such programs showed that 
the average annual employer cost of $144 per employee represented a cost- 
savings of $358 per participant in 2009 dollars (13). Most of the studies 
evaluated were implemented in companies with more than 1,000 employees and 
were centralized; it is not clear if these findings can be generalized to smaller 
organizations. Since firms with fewer than 500 employees represent 99.7% of 
U.S. employers, more efforts to promote workplace wellness programs and 
reduce perceived barriers of affordability are warranted. In particular, 
development of programs that are affordable for small businesses is needed 
(14).
The purpose of the following study was to evaluate whether a worksite 
health promotion (WHP) improves health risk factors in employees and is cost- 
effective to the employer of an organization that is small in size and is 
decentralized.
Methods
For a detailed description of methods, see Chapter 1.
Cost-effectiveness ratios in the present study are presented from the 
perspective of the employer and are based on data from year 1 of the 
investigation. Costs are reported as direct employer costs in 2006 dollars. Costs 
for the intervention include compensation for the author to present the
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educational material and administer the program, facilitation of remote site food 
demonstrations and teleconferencing services (includes scheduling and 
technologist support). Cost of the intervention was measured as the per-capita 
cost for the intervention (I) group. Per capita costs for health screening for both 
the I group and the comparison (C) group were equal and are not included in the 
cost- effectiveness calculation and no costs for material development are 
included. Relative percentage point reduction, in the key marker, LDL-C, was 
used as the primary measure of efficacy. A secondary effectiveness outcome 
measure was the absolute change in CHD risk (ACHD risk).
Computation of relative and absolute changes in LDL-C and CHD risk was 
based on the calculations of Soler et al., in their 2010 review of the effectiveness 
of worksite health interventions (15)(See Chapter 1).
The ten-year risk for the development of CHD was calculated using the 
Framingham Risk Score (FRS) and reported as a percentage. The FRS is an 
established formula that uses the measured risk factors: age, TC, HDL-C, SBP, 
treatment for hypertension, and cigarette smoking and is a well-accepted tool for 
health professionals (16). Risk was evaluated as follows: low risk = < 10%, 
intermediate risk = > 10% and < 20%, and high risk = > 20% (17).
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Results
A detailed description of clinical results is presented in Chapter 1.
At 12 months, LDL-C was significantly less in the I group than the C group 
(110.86 ± 4.4 mg/dl, 126.67 ± 4.0 mg/dl respectively, p = 0.011) and approached 
significance from the baseline value (p = 0.06) a relative decrease of 13.4%.
LDL- C was not different at 12 months from baseline in the C group. TC in the I 
group decreased significantly from baseline to a value that was also significantly 
less than that found in the C group at 12 months (183.4 ± 4.4 mg/dl, 198.6 mg/dl, 
respectively, p = 0.001 within group, 0.013 between groups). TC in the C group 
was not different from baseline at the end of one year. The mean WC of the C 
group increased significantly from baseline, (98.8 ±1.0 cm, p= 0.001); there was 
no change from baseline in the mean WC among the I group. No other within- 
group or between-group differences in weight, BMI, PCTFM, TBWPCT, SBP, 
DBP, HDL-C, TC/HDL, TRG, FG or hsCRP were found.
Chi-square analysis of the FRS score of the C and I group at 12 months 
(1.8 ± 0.5,1.9 ± 0.5) showed no significannt between-group or within-group 
differences from baseline. However, the absolute reduction in CHD risk of the I 
group was 0.3 percentage points, a relative improvement of 18% in a population 
estimated to be low-risk at baseline. The results of health screening tests are 
shown in Table 1.3, Chapter 1.
Direct employer cost for the Intervention was $136.27 per participant in 
2006. (Table 2.1). Cost effectiveness of the Intervention was $10.17 per
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percentage point reduction in LDL-C and $454.23 per point reduction in CHD 
risk. (Table 2.2).
Table 2.1 Per capita cost ($) for one year University of New Hampshire Cooperative 
Extension Worksite Health Promotion for Intervention participants
INTERVENTION EDUCATION Cost ($)*
Videoconferencingb 35.00
Wellness program managed 58.33
Remote site coordination 10.00
Pedometers 32.94
COST FOR INTERVENTION 136.27
a2006 dollars
bVideoconferencing includes scheduling and technical support
'Wellness educator (35 hrs - delivery of program, communication with participants and administration time) 
Administration, food demonstrations
Table 2.2 Comparison of cost-effectiveness ratios for one year UNH Cooperative Extension 
Workplace Health Promotion (WHP) with cited references
Measure of 
Effectiveness
UNH WHP C-E Ratio Reference Reference C-E Ratio
LDL-C
$10.17 per relative % 
point reduction
Economic analysis of Killilea 
and Funk (18)
$12 to $19 per relative % 
point reduction
CHD Risk $454.23 per absolute 
point reduction
Intervention study by 
Finkelstein, etal. (19)
$470 per absolute point 
reduction
C-E ratio = cost-effectiveness ratio, LDL-C = Low density lipoprotein cholesterol
CHD Risk = the ten-year risk for the development of CHD using the Framingham Risk Score (16)
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Discussion
Findings of the present study show that a worksite healthy lifestyle 
program can reduce the CHD risk factor LDL-C by 13%. Substantial evidence 
exists that reduction of LDL-C also reduces the risk of heart disease (6). The 
calculated 1.4% CHD risk reduction per percentage point reduction in LDL-C 
achieved in the present investigation is comparable to that of other studies that 
identified the CHD risk-reduction benefit achieved per unit of LDL-C reduction 
(20).
Since the consequence of the failure to prevent disease is often treatment, 
economic comparisons of this study are made in relation to both pharmaceutical 
and lifestyle interventions. HMG-CoA reductase inhibitor drugs (statins) have 
been established as agents for preventing CHD through LDL-C reduction. 
Although lifestyle interventions and pharmaceutical management of 
hyperlipidemia are both utilized for the primary prevention of CHD, it is believed 
that the most cost-effective means to curb CHD risk are lifestyle changes (6). 
Evidence that lifestyle changes are more cost-effective than drug treatment for 
LDL-C reduction is supported by the calculated C-E ratio of $10.17 per one 
percent reduction in LDL-C found in the present investigation. This compares 
favorably with the $12 - $19 per percent LDL-C reduction reported for statin 
treatments (18).
Finklestein et al. have published results of the on-going, multi-centered, 
study WISEWOMAN (21). These authors reported a C-E ratio related to changes 
in CHD risk of $470 per point reduction in the ten-year CHD risk for the wellness
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intervention (19). The C-E ratio of the present study was $454.23 per point 
reduction in CHD risk. Because WISEWOMAN examined the differences 
between a health screening group and a screening group plus educational 
intervention in CHD risk reduction, it is a suitable cost-effectiveness comparison 
with the present findings. The investigators of WISEWOMAN reported that the 
program is a cost-effective approach for reducing CHD risk (19). Therefore, it can 
be claimed that the currently reported program is cost-effective as well.
The primary component of this intervention program was the educational 
sessions delivered by videoconferencing simultaneously, to different worksites of 
a decentralized organization. Delivery of the lifestyle education accounted for 
most of the expense of the intervention and amounted to $103.33 per participant. 
Potentially, this cost could be less per capita, since additional videoconference 
attendees add no cost. Moreover, access to the video conference could be 
broadened. Different types of workplaces and organizational structures may 
require flexible arrangements for the delivery of wellness education, particularly if 
the organization is small and decentralized. For example, live educational 
sessions might be viewed on personal desktop computers at work, as the most 
up-to-date software allows for remote internet viewing and archiving for later 
viewing. The use of technology can help to ease concerns about high costs and 
accessibility.
Limitations of the present study include the possibility that undesirable 
results prompted private interventions outside of the research protocol, as all 
participants were made aware of their testing results and received health
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newsletters. It was beyond the scope of the study to control for outside influences 
that would modify behaviors. However, no differences were reported in the use of 
prescription medications from baseline at 12 months in either group. Another 
limitation was that our sample size was relatively small and not selected for the 
presence or absence of pre-existing risk factors. It was the intent of the 
investigation to recruit the employees of a small organization which limited the 
potential subject pool. However, participation was 35% of employees; and 
analysis of baseline characteristics between groups indicated no differences in 
measures of CHD risk, including medication use. On the other hand, it could be 
argued that the unselected subject population strengthens the impact of the 
present results in that they reflect a typical employee population, which increases 
the generalizability of the findings. Because specific lifestyle changes associated 
with the improved LDL-C found in the I group of this study were not identified, 
future studies might include design methodologies that quantify lifestyle 
characteristics in a way that is standardized and comparable to other 
investigations.
Conclusions
Findings of the present study demonstrate that LDL-C and overall CHD 
risk can be reduced in a relatively healthy employee group following health 
screening and lifestyle education. The expense of a healthy lifestyle intervention 
delivered at the worksite by videoconference is cost-effective, when compared to 
the pharmaceutical option of statin administration, or lifestyle education in a 
clinical setting.
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A workplace health promotion program with an educational component 
delivered by videoconference can be a cost-effective method of supporting 
change that will translate into overall health and cost benefits for both employers 
and employees. If employers and employees can successfully participate in 
programs designed to improve the health of employees, at reasonable cost, both 
parties will benefit.
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CHAPTER 3: DIFFERENCES IN HEALTH PERCEPTIONS AND
BEHAVIORAL CHANGES BETWEEN GROUPS PARTICIPATING IN A 
WORKSITE HEALTH PROMOTION 
Introduction
Preventable chronic health problems such as cardiovascular disease 
(CVD), type II diabetes and metabolic syndrome are costly to society, individuals 
and to employers. Workplace Health Promotions (WHPs) are known to be 
effective in chronic disease risk reduction and can be implemented at reasonable 
cost, benefitting both the employer and employee (1). See Chapters 1 and 2.
Cooperative Extension is the federally-mandated outreach arm of the 
University of New Hampshire charged with bringing educational programs based 
on current research to the public, often free of charge. As a worksite, Extension 
is unique because it is decentralized, its offices spread geographically throughout 
the state, and is equipped to help local communities and business invest in good 
health (2). Nutrition, health care strategies, financial management, and workforce 
education (including WHP) are examples of outreach programs that might be 
offered by Extension (3).
Extension expertise meets public needs at the local level, and has utilized 
multi-dimensional strategies for educational outreach that include the innovative
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use of technology (4). Extension professionals are both leaders and community 
members and are in a position to apply multifaceted approaches in promoting 
healthier lifestyles. Often the design of those programs incorporates research 
from more than one academic discipline. In addition to utilizing knowledge gained 
from nutrition and exercise science, healthy lifestyle promotion is guided by 
research on how people think and what influences their behavior (5).
There are many theoretical models of health behavior with the common 
underlying premise that several psychosocial characteristics contribute to lifestyle 
behaviors. (Table 3.1). Nutrition education, as it relates to health, does not 
espouse a singular health behavior change theory specific to the discipline. 
Components of multiple theories have been borrowed and applied to predict 
health behaviors. However, none of the current theoretical models fully predict 
behavior change; and, it has been suggested that combining compatible theories 
may therefore be the most effective approach in nutrition education as it relates 
to health (6). A review of the literature noted that many variables are common 
among key theories and that studies often use compatible variables from related 
theories (7). Self-efficacy (confidence), decisional balance (importance) and 
commitment are examples of variables that are measured to predict health 
behavior change (8).
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The KAB model relies heavily on the concept that 
knowledge is not only essential but provides motivation 
and attitude to make positive health changes (6).
Health Belief Model (HBM)
HBM propose that health-related action is dependent on 
sufficient motivation to make health relevant, the belief 
that health risk is present, belief that a behavior change (if 
perceived barriers can be overcome) will reduce risk, and 
that the behavior change is achievable. The emphasis of 
the HBM is that a perceived threat is the motivating force; 
perceived benefits (less barriers) become incentives for 
behavior change (9).
Transtheoretical Model (TTM) / 
Stages of Change (SOC)
TTM aka SOC originated from analysis and integration of 
common processes that individuals use to make changes 
in behavior. This model proposes that health behavior 
change can be seen as a continuum based on an 
individual's readiness to change. This change is gradual 
and occurs through a series of stages: precontemplation, 
contemplation, preparation, action and maintenance. TTM 
suggests that self-efficacy and weighing the pros and 
cons of change are important mediators of change (10).
Social Cognitive Theory (SCT)
The SCT model of health behavior change assumes that 
knowledge of health risks and the related lifestyle habits 
create the precondition for behavior change. The central 
role of self-efficacy is considered a core determinant of 
effective action. Self-efficacy in this model differs from 
confidence in that it includes both an assertion of 
capability to engage a behavior (“I can do this.”) and the 
conviction that the behavior will occur (“I can do this and I 
will do this.”). Short- term attainable goals are stressed as 
tools for the incremental development of self-efficacy (11).
6. Achterberg C. J Nutr Educ Behav 2004;36:40-2.
9. Rosenstock IM. Health Educ Q 1988; 15:175-83.
10. Prochaska JO. Prog Clin Biol Res 1984;156:131-40.
11. Bandura A. Health Educ Behav 2004;31:143-64.
The aim of the present study was to evaluate whether or not there were 
differences in health perceptions and lifestyle behaviors after participation in a 
WHP between an intervention (I) group receiving group lifestyle education via
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interactive teleconference plus e-mailed newsletter and a comparison (C) group 
receiving lifestyle education through e-mailed newsletter only.
Methods
Study participants were volunteers from the employees of UNH 
Cooperative Extension. All employees were screened at baseline, 12 months and 
24 months for anthropometric, clinical, dietary and biochemical risk factors for 
CVD and metabolic syndrome and completed health questionnaires. In addition, 
participants completed an exit survey at 24 months. All participants received hard 
copies of their screening results as well as periodic newsletters related to healthy 
lifestyles via email. The primary component of the intervention was educational 
sessions that were interactive and delivered simultaneously across the state by 
videoconference technology. The I group also received pedometers and 
instructions to report the number of steps taken weekly. The principal sources of 
data used to determine the health perceptions and behaviors of the participants 
were a Health Questionnaire at baseline, 12 and 24 months, along with an Exit 
Survey at 24 months. Differences in health perceptions and behaviors were 
measured using the following variables: Importance, Readiness to Change, 
Confidence, Commitment and Barriers. (Table 3.2). These data were examined 
separately, and in some cases, analyzed relative to clinical outcomes such as 
waist circumference (WC). Interpretation of open-ended responses was tested 
for agreement among three raters using an online calculator developed 
specifically for use when multiple raters are not restricted in the number of codes
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that are assigned to a singular response. The free-marginal kappa (Kfree) of 0.70 
or above indicates adequate interrater agreement (12). (Table 3.3).
Table 3.2 UNHCE Workplace Health Promotion 
Health Behavior and Perception Questionnaire Variables
Definition aiven to oarticiDants: Lifestyle chanaes are chanaes to improve vour health, such as adiustina vour diet, 
increasing your physical activity, and changing health-related behaviors.
Variable Assessment Question
1. Importance
Put an X on the line below to show, on a scale from 0 to 10, how important it is for you 
to make lifestyle changes. (0 Not very important, 5 Somewhat important, 10 Very 
important)
2. Readiness to 
change
Put an X on the line to show how ready you are right now, on a scale of 0 to 10, to make 
lifestyle changes. (0 Not very ready, 5 Somewhat ready, 10 Very ready)
3. Confidence Put an X on the line to show how confident you are, on a scale of 0 to 10, that you can 
make lifestyle changes. (0 Not very confident, 5 Somewhat confident, 10 Very confident)
4. Commitment What lifestyle changes would you be willing to make?
5. Barriers What things might make it hard for you to make lifestyle changes?
Variables 1 -3  were quantitative questions and answered on a scale of 0 -1 0 . Variables 4 and 5 were open-ended 
questions and analyzed according to category code of each response as well as by frequency counts; i.e., number of 
lifestyle change and number of barriers perceived.
Detailed descriptions of the Questionnaire, Exit Survey methods, teleconference 
educational sessions and statistical treatment of data can be found in Chapter 1 
and the Appendix . Newsletters can be viewed on the enclosed CD.
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Table 3.3 Interater Agreement (Kfree)(13) for Open-ended Responses from UNHCE Workplace Health
Promotion Exit Survey and Health Questionnaire
Kfree1 Questionnaire Commitment and Barriers Questions
0.82 What lifestyle changes would you be willing to make?
0.78 What things might make it hard for you to make lifestyle changes?
0.76
As a result of participating in the UNHCE Workplace Wellness program: What lifestyle changes (for example, 
healthy diet and activity choices, health maintenance and stress management) have you made? Please be 
specific.
0.83 As a result of participating in the UNHCE Workplace Wellness program: What health changes have you 
made? Please be specific.
0.68 Should UNHCE have a Workplace Wellness Program? Why or why not?
0.33 Please comment on the UNHCE Workplace Wellness program (what did you like; what did you dislike; do you 
have any suggestions for changes?
1. Values of kappa can range from -1.0 to 1.0, with -1.0 indicating perfect disagreement below chance, 0.0
indicating agreement equal to chance, and 1.0 indicating perfect agreement above chance. A rule of thumb is 
that a kappa of .70 or above indicates adequate interrater agreement.(12)
Results 
Major clinical and dietary outcomes
At year one from baseline, WC and Mets markers (MetS) increased 
statistically in the C group; Total (TC) and LDL-cholesterol (LDL-C) decreased in 
the I group. The I group consumed a lower ratio of dietary omega-6 to omega-3 
fatty acids than reported by the C group at 12 months. Additionally, the I group 
decreased their intake of unspecified fats from baseline, a group of dietary fats
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that includes trans fats. The I group participants also increased the average 
steps taken per day and maintained the level throughout the year. In year two, 
the changes in TC, LDL-C and MetS were sustained. A decrease in WC in the I 
group resulted in a significant difference from that of the C group at 24 months.
Complete results of anthropometric, clinical, dietary and biochemical tests 
are found in Chapter 1.
Health Questionnaire
At baseline, 18 of 31 C group (58.1%) and 20 of 29 I group (69%) 
completed questionnaires. At 12 months, questionnaires were completed by 16 
of 29 C group (55%) and 14 of 26 I group (53%). At 24 months, 19 of 23 C group 
(78.3%) and 17 of 20 I group (85%) returned questionnaires. Seventy percent of 
the participants from each group who completed the entire 24 months of the 
WHP returned all three questionnaires, (16 of 23 C group, 14 of 20 I group).
No differences were seen between groups, at baseline, 12 months or 24 
months in responses related to frequency of medical check-ups, out-of-pocket 
medical expenses, sick-day absences, medication use and consumption of 
dietary supplements.
Importance, readiness to change, confidence, and stress levels. There 
were no differences between or within groups found in the scaled responses (0 - 
10) to queries of how important it is to make lifestyle changes, readiness to make 
lifestyle changes, confidence in ability to make changes or in level of stress in 
year one or in year two. (Table 3.4).
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Table 3.4 Scaled Measures of Importance, Readiness to Change, Confidence and Stress
Year 1 Year 2
Variable
(0 -1 0 )
Comparison 
Baseline 12 mos
(n = 24) (n =16)
Intervention 
Baseline 12 mos
(n = 23) (n = 17)
Comparison 
12 mos 24 mos
(n = 19) ( n = 12)
Intervention 
12 mos 24 mos
( n = 18) (n = 12)
Importance 8 .0 ± 0.3 8.0 ± 0.3 8.0 ± 0.3 8.2 ± 0.3 8.5 ± 0.6 7.7 ± 0.6 8.6 ± 0.7 7.7 ± 0.7
Readiness to 
change
7.5 ± 0.3 7.9 ± 0.4 7.6 ± 0.4 7.0 ± 0.4 8.3 ±0 .6 7.6 ± 0.7 8.6 ± 0.7 8.4 ± 0 .7
Confidence 6.7 ± 0.4 6.6 ± 0.4 6.8 ± 0.4 6.6 ± 0.4 7.6 ± 0.7 7.7 ± 0.8 8.1 ± 0.8 8.5 ± 0.8
Stress level 5.6 ± 0.4 5.4 ± 0.5 5.6 ± 0.5 5.0 ± 0.6 5.3 ± 0.8 5.3 ± 0.8 5.4 ± 0.8 5.0 ± 0.9
Least square means of quantitative Questionnaire variables in year 1 and year 2. General linear model performed 
using age and gender as covariates and post-hoc analyses were conducted using Tukey’s Honestly Significant 
Difference test. The level of statistical significance was set at p < 0.05. Between group and within group analyses are 
all NS. Data are presented as LSM ± SE on a scale from 0 -1 0 .
Commitment and Barriers. In response to the question “ What lifestyle 
changes are you willing to make”, no statistical differences in the in the number 
of lifestyle changes that participants would be willing to make were reported 
between groups or within groups during year one. At 24 months, the I group 
reported they were willing to make significantly more lifestyle changes than at 12 
months (2.47± 0.2, 1.98 ± 0.2 respectively, p = 0.04) which was also more than 
the C group reported at 24 months (1.75 ± 0.2, p = 0.002). Chi square analysis of 
the individual response categories (none, consume healthier diet, increase or 
maintain exercise, both healthier diet and exercise) for this question at baseline, 
12 month and 24 months showed no statistical differences between groups.
In response to the question “What things might make it hard for you to 
make lifestyle changes”, no significant differences in the number of barriers to
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making lifestyle changes were identified between or within groups. However, the 
number of barriers reported by the I group at 12 months (1.84 ± 0.2) trended 
higher than at baseline (p = 0.07), and higher than reported by the C group (p = 
0.08) at 12 months. There were no differences seen in either group in year 2 or 
between groups at 24 months. Chi square analysis of the individual response 
categories (none, time conflicts, family, stress/illness) for this question at 
baseline, 12 months, and 24 months was not different between groups. The most 
frequent response given by both groups was “time conflicts” (C group 67%, I 
group 64%).
In response to the question “Has participation in UNH Cooperative 
Extension Workplace Wellness Study impacted your lifestyle (diet and activity 
choices, health maintenance and stress management)”, more I than C group 
reported “improved” (83% vs. 58 %), a differences that approached significance 
at p = 0.09. Significantly fewer I group than C group participants (11 % vs. 42 %, 
p = 0.034) reported “no change”. Only one participant ( I group) reported 
“worsened”, which was not significant between groups.
In response to the question “Has participation in UNH Cooperative 
Extension Workplace Wellness Study impacted your health”, no differences 
between groups were found. “Stayed the same” was the response of 37% of C 
and 33% of the I groups while “Improved” was reported by 58% of the C and 67% 
of the I groups. Only one respondent reported “Worsened” (I group) and this was 
not significantly different from C group.
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In response to the question “Has participation in UNH Cooperative 
Extension Workplace Wellness Study impacted how you feel”, no differences 
between groups were found. “Stayed the same” was the response of 42% of C 
and 36% of the I group participants while “Improved” was reported by 58% of the 
C and 64% of the I group. No respondent reported “Worsened”.
Exit Survey
Exit Surveys at 24 months were completed by 17 of the 23 C participants 
(74%) and 18 of the 20 I participants (90%).
In response to the Exit question “As a result of participating in the UNHCE 
Workplace Wellness program: What lifestyle changes (for example, healthy diet 
and activity choices, health maintenance and stress management) have you 
made? Please be specific.”, significantly more of the I group than the C group 
participants reported increased physical activity (84.2% vs. 41.2 % , p = 0.007) 
and improved diet (63.2% vs. 29,4 %, p = 0.043). One-third of the I group 
reported increased health awareness (for example, “ increased awareness of 
healthy diet or increased awareness of need for physical activity”) while no C 
group participants gave a similar response (33.3% vs. 0%, p = 0.17). Twenty-four 
percent of the C group reported making no specific lifestyle changes compared to 
zero percent of the I group giving this response (p = 0.025).
In response to the Exit question “As a result of participating in the UNHCE 
Workplace Wellness program: What health changes have you made? Please be
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specific.”, fifty percent of the C group reported making no specific health changes 
at all, compared to 16.7% of the I group (p = 0.04). (Figure 3.1 A)
Figure 3.1 A. Lifestyle and Health Behavior Changes Reported in Exit Survey
Lifestyle and Health Changes
N o specific health  changes  
N o specific lifesty le  changes
Im proved  d ie t  
Increased exercise
■  In te rv e n tio n
■  C om p arison
Increased health  aw areness
0 20 40 60 80 100
Percent o f Group Responses p = < 0.05
Significant differences between groups in response to Exit Questions regarding lifestyle and health changes made as a 
result of participation in the UNH Cooperative Extension Workplace Health Promotion. Pearson’s Chi square analysis 
was used to examine category responses between groups. Data are presented as the percent of all responses within 
each group. The level of statistical significance was set at p < 0.05.
In response to the Exit question “Should UNHCE have a Workplace 
Wellness Program? Why or why not”, there were no differences between groups. 
Both groups gave a strongly positive response to the query (C group 83.3% vs. I 
group 88.9%). Two respondents in each group responded “maybe”, and the 
single negative response was given by a C group participant. (Figure 3.1B).The 
most frequent reasons given were “positive impact on health” (C group 83.3%, I 
group 88.9%) and “positive effect on work environment” (C group 27.8%, I group 
38.9%).
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Figure 3.1 B Participants’ Support for a Workplace Health Promotion
Should UNHCE have a Workplace 
Wellness Program?
M a y b e
Yes
No
■  In te rv e n tio n
■  C o m p arison
0 20 40 60 80 100
Percent of Group Responses
Responses to Exit Question “Should UNHCE have a Workplace Wellness Program”. Pearson’s Chi square analysis 
was used to examine category responses between groups. Data are presented as the percent of all responses within 
each group. The level of statistical significance was set at p < 0.05. All categories are NS.
In response to the Exit question “Please comment on the UNHCE 
Workplace Wellness program (what did you like; what did you dislike; do you 
have any suggestions for changes”, unfavorable comments were more likely to 
be made by C group participants than I group participants (50% vs. 5.5 %. p = 
0.024) and favorable comments were more likely to be given by I group 
participants, although the large majority of subjects from both groups made at 
least one favorable remark (100%, I group vs. 75%, C group. P= 0.003). There 
were no strictly unfavorable comments. Many responses listed satisfaction with 
most or some of the program protocol and added what was disliked, for example, 
“I liked the monthly meetings and the information that was given. I didn't like 
keeping track of our activity.” The I group was more likely to report liking some 
aspect of the study protocol (for instance, “Screenings were helpful with
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immediate feedback” or “I liked the newsletters”) than the C group (83.3% vs. 50 
%, p = 0.038), while the C group was more likely to report disliking some clinical 
aspect such as “fingerstick” or “fasting” of the study protocol (50% vs. 11.1%, p =
0.013).
Correlations between clinical variables and questionnaire responses
Multiple regression analyses were used to determine if any of the behavior 
variables during the intervention year one could explain changes in waist 
circumference or the number of lifestyle changes reported.
Regression analysis, using WC at 12 months as the dependent variable, 
showed that 68% of the variance of all participants could be predicted by three 
variables: CRP at 12 months (r = 0.53, p <0.001), intake of dietary unspecified 
fats at 12 months (r = -0.205, p = 0.1) and the reported confidence in one’s ability 
to make changes as reported at baseline (r = -0.49, p = 0.001). Regression 
analysis using the number of specific lifestyle changes reported by participants in 
the exit survey as the dependent variable showed that 15% of the variation found 
could be predicted by the reported confidence in ability to make changes at 24 
months (r= 0.0.39, p = 0.027).
Separate regression analyses were done for the C and I group data using WC at 
12 months as the dependent variable; independent variables were CRP at 12 
months, and these variables: importance of changing at 12 months, readiness to 
change at 12 months, and confidence at 12 months. In all cases, CRP was 
strongly and significantly correlated with WC at 12 months. In the C group,
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importance (r = -0.5, p = 0.002) and readiness to change (r = -0.40, p = 0.02) 
were significantly correlated to WC; confidence (r = -0.34, p = 0.06) was nearly 
significantly negatively correlated with WC at12 months. In the I group, none of 
the three additional variables were significantly correlated with WC at 12 months. 
(Table 3.5). Additional regression analyses of data from each treatment group 
using WC at 24 months as the dependent variable, CRP at 24 months and 
confidence at 24 months as the independent variables were done. In both 
groups, confidence at 24 months was inversely related to WC at 24 months, but 
was only significant in the I group, and trending toward significance in the C 
group.
Discussion 
Relationship of health perceptions and behaviors to intervention and 
clinical outcomes
The present study indicated that health perceptions and behaviors of participants 
in a WHP designed to reduce CVD risk were dissimilar between a comparison 
group receiving only minimal information in the form of e-mailed newsletters and 
an intervention group that also participated in a series of interactive educational 
sessions delivered by videoconference. We were able to identify an association 
of health perception variables with the clinical risk factor of waist circumference, 
as well as with a measure of behavior change (number of lifestyle changes 
made). In addition, the measure for commitment to change in the I group
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Table 3.5 Regression Analyses Performed Separately by Treatment Group Using Waist 




Independent Variable Std Coefficient P
Constant 0 <0.00
CRP (12 mo) 0.7 <0.00
Importance (12 mo) -0.50 0.002
Intervention
R2 = 0.5 II
Independent Variable Std Coefficient P
Constant 0 0.005
CRP (12 mo) 0.65 0.004
Importance (12 mo) 0.27 0.17
R2 = 0.67 N = 17
Independent Variable Std Coefficient P
Constant 0 <0.001
CRP (12 m) 0.71 <0.001
Ready to Chg (12 mo) -0.40 0.02
R2 = 0.39 N = 18
Independent Variable Std Coefficient P
Constant 0 <0.001
CRP (12 mo) 0.59 0.01
Ready to Chg (12 mo) 0.2 0.34
R2 = 0.62 N = 17
Independent Variable Std Coefficient P
Constant 0 <0.001
CRP (12 mo) 0.71 0.001
Confidence (12 mo) -0.34 0.06
R2 = 0.43 N = 18
Independent Variable Std Coefficient P
Constant 0 <0.001
CRP (12 mo) 0.66 0.004
Confidence (12 mo) 0.054 0.79
Separate regression analyses of Comparison and Intervention groups using waist circumference at 12 months as the 
dependent variable. CRP, importance, readiness to change and confidence were used as independent variables. The 
level of statistical significance was set at p < 0.05.
increased during the study and was greater than in the C group at 24 months. 
Intervention group participants reported increases in physical activity and 
improved diet, as well as greater health awareness as a result of study 
participation.
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Behavior change that results in a healthier lifestyle is likely to result in a 
physiologic shift toward wellness that can be measured. We found an association 
between confidence in the ability to make changes and waist circumference, an 
important risk factor for CVD, type II diabetes and metabolic syndrome.
Individuals within the entire cohort who had lower confidence levels at baseline, 
were less likely to maintain or reduce their waist circumference over the first year 
of the study; this effect remained for the C group but not the I group, when the 
treatment groups were analyzed independently. It is noteworthy that, in the I 
group, WC at 12 months correlated positively with the response to importance of 
change queried at baseline. It did not correlate however, with other baseline 
variables of perception. The positive relationship between clinical measures and 
perceived importance may indicate that individuals in the I group with a larger 
WC entered the study with a greater sense of need for change than others, even 
though at baseline, the WC of the groups was not found to be different. Waist 
circumference increased significantly in the C group at 12 months, but not in the I 
group.
The greatest difference, and probably the most relevant, related to health 
perceptions between groups was seen at 12 months. In the I group at 12 months, 
WC did not correlate with the variables of perception (importance, readiness to 
change, or confidence). This differs from findings of the C group in that WC at 12 
months was associated negatively with “importance” and “readiness to change”; 
in addition, there was a negative trend with “confidence”.
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Our findings are similar to those of Hankonen et al., who compared the 
effect of personality with health-related self-efficacy on the change in WC over 12 
months. They found self-efficacy to be positively related to WC reduction 
following group lifestyle intervention. They also noted that baseline self-efficacy 
had no effect on waist circumference change at 12 months (14). What this 
suggests is that the level of self-efficacy before a start to make lifestyle changes 
may not predict those who will be successful in their attempt; and reinforces the 
notion that self-efficacy is modifiable and a practical target for intervention 
programs.
The results of the relationship of “importance” to WC in the I group 
between baseline and 12 months were somewhat inconsistent. These findings 
may support the assertion that behavior change had occurred during the year in 
the I group; therefore reducing the importance of making further change.
Confidence in the ability to make changes had a positive association with 
the number of lifestyle changes made during the 24 months by the present study 
in the entire cohort, and was independent of treatment group. This would seem to 
be the case regardless of the mode of information received by the participants.
These findings suggest that individuals of both treatment groups, who had 
showed greater confidence in their ability to make lifestyle changes, at 24 
months, also reported making more lifestyle changes. We did not find an 
association between the perception of importance of change, or the readiness to 
change with the number of lifestyle changes made.
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Commitment, measured in the present study by the number of lifestyle 
changes participants were willing to make, did increase significantly in the I group 
by 24 months, but not in the C group. Additionally, the I group reported making 
more lifestyle changes than the C group; and more of the I than C group 
participants claimed to have an improved lifestyle as a result of study 
participation. These results are somewhat consistent with those of a cross- 
sectional study done by Kelly to determine the predictive ability of behavioral 
variables on changes in diet. In that study, neither confidence nor importance 
was a significant predictor of change. However in that study, commitment to 
change was found to be the most influential and the most predictive variable of 
stage of change. Commitment values increased with each progressive stage of 
change, being strongest in the Action and Maintenance stages (8). We could 
assert that the evidence of increased commitment along with increased number 
of lifestyle changes made in the present study indicate a transition to an action 
stage in our intervention group.
Taken together with the findings of the Kelly study, this suggests that the I 
group transitioned through the stages of change resulting in behavior changes 
that were not observed or reported in the C group. Further evidence in support of 
that interpretation was found in our study at 12 months, when the I group 
identified more barriers to making lifestyle changes than at baseline, and when 
compared to the C group at 12 months. Contento maintains that both self- 
efficacy and decisional balance (importance) may change over a course of action 
as the new behavior may turn out to be more difficult than originally perceived
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(15). It stands to reason that individuals who made efforts towards meaningful 
change would encounter some unforeseen barriers to adopting a new behavior, 
and therefore, improve self-efficacy as the change becomes habit, a process that 
was not expected for the C group. The periodic education over 24 months may 
have provided the I participants with more lifestyle success “tools” over time, 
allowing for repeated mastery of the new behavior, and thus, increased self- 
efficacy.
Videoconference as an effective health promotion tool
The use of technology facilitated the WHP intervention of this study in a 
statewide decentralized worksite, although technology use for such programs is 
not novel. Distance education for workers delivered online or by 
videoconference, has been found to be efficacious and economical (1, 16) and 
educators have found interactive distance learning to be as effective a learning 
environment as traditional face-to-face methods (17).
In the present study, the simultaneous delivery of educational information 
and interactive component of the intervention was made possible by the use of 
an existing videoconferencing network. Ricketts and colleagues used a similar 
network to compare the efficacy of nutrition education via a videoconferencing 
network with the same curricula also delivered in traditional face-to-face 
instruction to health educators. The technology-based distance format was found 
to be equivalent to the traditional method in attendee satisfaction and learning 
(18). Employee acceptance of the presently investigated WHP was high. The 
participants in both treatment groups expressed strongly positive sentiments on
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the value of a WHP, emphasizing positive impacts on health and work 
environment.
We did not test for learning outcomes in this study and cannot comment 
on the degree of learning differences, if any, between the treatment groups. 
However, both changes in the clinical variables and reported lifestyle 
modifications suggested that increasing awareness of a connection between 
lifestyle behaviors and health and wellness translated into perceptual and 
behavioral differences between groups, resulting in measurable clinical 
differences.
Since the face-to-face (albeit distant) education sessions on changes in 
lifestyle were the primary intervention between the treatment groups, it could be 
argued that videoconferencing is an effective means of facilitating health 
promotion that is associated with improvement in health risk factors, mediated by 
positive lifestyle changes and perceptions of health.
UNH Cooperative Extension WHP as an internal and external model
The usefulness of the present study of Cooperative Extension employees 
goes beyond the positive effects on health that occurred among participants. As 
an outreach organization, Extension has the opportunity to partner with 
employers in the community to provide or support efforts to engage in a WHP. A 
study of an external WHP facilitated by Extension personnel found that 
participants reduced body weight, WC, increased exercise, and improved their 
readiness to increase exercise and eat more fruits and vegetables (2).
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Furthermore, Extension has provided valuable insight and experience in guiding 
the development of a WHP at the University of Vermont, based on their own 
employee wellness program (19).
A recent recommendation for Extension programs related to providing 
assistance for worksite wellness initiatives is “Practice what you preach”. 
Extension will increase its credibility as a community partner if there are similar 
internal efforts to support their own employees through policies or education (2).
Strengths and limitations
One of the strengths of this study was the 12 month initial intervention 
phase, followed by a less intense maintenance period of 12 months. Many 
studies of WHPs or of health behavior models examine changes that occur over 
a shorter period of time. We are able to assert that our findings occurred over 
time and were sustained for a longer term. However, there was attrition in our 
relatively small participant population, resulting in decreased statistical sensitivity 
throughout the 24 month period.
A limitation of our study was the fact that many of our results are taken 
from self-reported data and may suffer from bias or respondent burden overtime. 
It is possible that our lower response rates, in particular at 12 months, resulted in 
a loss of statistical power to measure statistically significant changes. Another 
limitation was related to the instruments used to collect descriptive and 
perceptual data as these were designed to be used for clinical rather than 
research purposes. Future studies that include measures of psychosocial
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influence on behavior change should consider using existing validated 
instruments designed for that purpose. However, the primary outcomes of this 
study were the measured clinical data that were collected by the researcher, and 
the secondary outcomes collected by survey or questionnaire were used to 
support those clinical outcomes.
Conclusions
Findings of the present study demonstrate that a lifestyle education 
component of a worksite health promotion delivered by videoconference 
(intervention) can be more effective than education by newsletter alone 
(comparison treatment). Employees who received education by videoconference 
improved clinical measures in their total cholesterol, LDL-cholesterol, waist 
circumference, markers of metabolic syndrome and they reported both increased 
physical activity and improved diets. The perception of improved lifestyle, even in 
the presence of barriers, was present in the intervention employees. On the other 
hand, perceptions of importance of lifestyle change, readiness to change, and 
confidence in the ability to change, were negatively associated with the health 
risk factor of waist circumference in the comparison group only. The WHP 
intervention likely resulted in increased knowledge and heightened health 
awareness that translated into behavior change and resulted in improved health 
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B. Informed Consent Form
Cooperative Extension Informed Consent Information
Purpose
The purpose o f this research p ro jec t is to  g a th e r d a ta  fro m  a w orkp lace  wellness p ro g ram  a t C o o p e ra tiv e  
Extension.
Description of General Health Screening
Health Questionnaire and Dietary Intake -  A  th re e  day d ie ta ry  record  w ill be ana lyzed  fo r  n u tr ie n t in ta k e  
and balance o f n u trien ts  in d ie t and a h ea lth  q u e s tio n n a ire  filled  o u t. Metabolic Screening -  A sm all b lood  
sam ple  (fin ger stick) w ill be ta k e n  to  m easu re  b lood levels o f  fasting  sugar, fats, and cho les te ro l a long  
w ith  blood pressure and w a is t c ircu m ference . Pulmonary Function Test -  Forced e x p ira to ry  a ir f lo w  in 
one  second and Peak Exp iratory Flow w ill be m easured  using h andhe ld  flo w  m eters . Body Composition -  
Analysis o f to ta l body fa t w e ig h t and fa t  fre e  w e ig h t (m uscle and b on e) w ill be d o n e  by b io e lec tric  
im pedance, a th re e  m in u te  tes t using painless e lectrod es  on th e  hand and  foot s im ila r to  th o s e  o f  an  EKG. 
All tests w ill be d on e  tw ic e , a t th e  s ta rt and a fte r  tw e lv e  m o n th s , excep t fo r  m etabo lic  screen ing , and  
p ulm onary  fun ctio n  w hich  w ill b e  m easured  a t th e  s ta rt, 6 a n d  12 m o n th s  later. S o m e e m p lo y e e s  w ill 
rece ive  p rin ted  edu catio na l m ateria ls  o n ly  and som e em p loyees  w ill also partic ipate  in an  ed u c a tio n  
program  and th e ir  physical activ ity  m o n ito re d  w e e k ly  using p ed o m e te rs . Em ployees in th is  g ro up  w ill 
in te ra c t w ith  th e  p ro gram  le a d e r and a tte n d  m o n th ly  lun ch tim e  m eeting s . The g roups w ill be c o m p a re d  
to  d e te rm in e  e ffectiveness.
Benefits and Risks
T he  general h ea lth  screening has th e  p o te n tia l to  h e lp  each e m p lo y e e  identify  s tren g th s  and w eakn ess  in 
lifestyles and d ie ta ry  hab its  th a t can be m o d ified  regard less o f  th e  g ro u p  assignm ent. P artic ip an ts  w ill be  
given results fro m  cho lestero l, trig lycerid e , glucose, b lood pressure, b o d y  com position  and  p u lm o n a ry  
tests. A lthough these  results a re  n o t d iagnostic, th e y  could b e  b rought to  a physician fo r  fu r th e r  
eva luation  if  a p artic ip an t so w ished . Testing  and in fo rm atio n  provided  w ill be fre e  to  p artic ip a n ts . Peak  
f lo w  m ete rs  w ill be fre e  to  partic ipants. T h e re  a re  fe w  risk associated  w ith  the fin g er stick p ro ce d u re . V e ry  
rare ly , dizziness o r ligh t-headedness occurs, w hich  can quickly  be a tte n d e d  to by tra in e d  s ta ff.
Confidentiality
Every e ffo rt w ill be m ad e  to  ensure  co n fid en tia lity . Test results will be coded  and n o t d ire c tly  associated  
w ith  yo u r n am e and w ill be used fo r d ata  m a n a g e m en t only.
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Consent Form for Participants in Cooperative Extension 
Workplace Wellness Program
I ,____________________________________________ (print name) have been informed and
understand that the information provided in the health questionnaire, three-day dietary record 
and test results of body composition, measurements of blood pressure, glucose, cholesterol, 
triglycerides and pulmonary function will be used for research purposes.
I have been informed and understand that my participation in the research is voluntary. I have 
been informed and understand that in reporting any information obtained in this program for 
research purposes, the protection of my identity will be maintained.
I have been informed and understand that the values obtained by the above tests are not 
diagnostic. If a question arises regarding these results, I understand that I may take them to my 
health care practitioner for further evaluation.
I have been informed and understand that if I have any questions or concerns about the use of 
my personal information, I should contact: Anthony R. Tagliaferro, Director- Center for Health 
Enhancement, Dept.of Animal and Nutritional Sciences, 518 Kendall Hall, 603- 862-1726. or 
anthonyt@cisunix.unh.edu.
I have been informed and understand that if I have any questions about my rights as a research 
subject, I can contact Ms. Julie Simpson in the UNH Office of Sponsored Research at 603-862- 
2003, or Julie.simpson@unh.edu to discuss them.
I agree to participate_____________________________________________  name/date.
Print Name____________________________________________________________
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Additional Clinical Results Not Shown




I 12 Months 





Grains (servings) 9.1 ±2 .6 5.2 ± 2.6 7.1 ±3.3 4.1 ±3 .3
Vegetables (servings) 1.5 ±0 .3 1.7 ±0 .3 1.8 ±0.4 2.4 ±0 .4
Fruit (servings) 1.2 ±0 .2 1.2 ±0.2 1.4 ±0.3 1.5 ±0 .3
Milk (servings) 1.8 ±0 .3 1.8 ±0.3 1.6 ±0.4 1.4 ±0 .4
Meat and Beans (servings) 7.3 ±1.2 6.1 ±1.1 9.4 ±1.5 8.4 ±1.5
Discretionary calories (Kcalories) 575.7 ± 86.2 420.4 ± 87.3 493.7 ±94.8 441.3 ±96.2
Grains (% of recommended) 88.1 ±12.8 96.6 ±12.8 99.8 ±16.4 53.8 ±16.6*
Vegetables (% of recommended) 44.4 ±11.8 57.7 ±11.6 58.5 ±14.9 82.9 ±14.8
Fruit (% of recommended) 63.8 ±13.0 65.9 ±13.0 69.1 ±16.1 77.4 ±16.3
Milk (% of recommended) 58.5 ± 9.9 60.2 ± 9.8 54.1 ±12.6 47.2 ±12.5
Meat and Beans (% of 
recommended)
114.5 ±21.0 95.6 ± 20.8 152.4 ±26.6 135.3 ±26.5
Discretionary calories (% of 
recommended)
176.0 ±26.2 168.3 ±26.4 152.6 ±32.1 141.6 ±32.5
* p < 0.05 within group.
Analysis of a subset of diet records returned by the same participants that completed records at both baseline and 12 
months. Food-group analysis was based on the portion sizes and categories of the former U.S. Department of 
Agriculture Center for Nutrition Policy & Promotion MyPyramid (www.MyPyramid.gov).
Analysis was performed using Diet Analysis Plus 8.0 using 3-day self-reported diet record. All variables corrected for 
age and sex. Statistical analyses were performed by general linear model using SYSTAT 12. Post hoc analysis was 
performed using Tukey's Honestly-Significant-Difference Test. Statistical significance was set at p < .05.
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D. 2 Pulmonary Measures Using Peak Flow Meters
Variable
Comparison Intervention
Baseline 12 months 24 months Baseline 12 months 24 months
n=21 n=4 n=8 n=20 n=4 n=9
PEF % Pred 78.8 ± 1.1 81.0 ±2.1 77.3 ± 1.5 79.1 ± 1.0 81.7 ± 1.9 81.3 ± 1.3
PEF avA per day( L/min) 36.5 ± 6.3 21.7 ±9 .9 24.0 ± 7.6 32.0 ± 6.2 20.2 ± 9.6 35.6 ± 7.3
FEV1 % Pred 96.0 ± 1.8 96.3± 3.4 88.8 ± 2.6 97.3 ± 1.7 100.4 ± 3.1 99.1 ± 2.2A
FEV1 avA per day (L) 0.3 ± 0.1 0.3 ±0 .1 0.2 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.3 ± 0.1
p < 0.05 between groups. Data are presented as LSM ± SE. Statistical analysis performed by General Linear Model 
using SYSTAT 12. Post hoc analysis was performed using Tukey’s Honestly-Significant-Difference Test. Statistical 
significance was set at p < 0.05.
FEV1 -  forced expiratory volume (L) in 1 second, PEF -  Peak expiratory flow rate (L/min)
% PRED FEV1, % PRED PEF - Test values were compared to predicted normal values for PEF (Nunn AJ, Gregg I. 
Bmj 1989;298:1068-70.) and FEVi (Crapo RO, Morris AH, Gardner RM. Am Rev Respir Dis 1981;123:659-64.); 
Percent of predicted = (measured PEF or F E V i) / (predicted PEF or FEVi) * 100
PEF avA per day and FEV1 avA per day = absolute difference between morning and evening measures of PEF and 
FEV1.
C. 3 Average Reported Steps per Day by Quarter Year 
Year 1 and Year 2 in Intervention Group
n Quarter Steps/Day P
Yearl
20 Baseline 5253 ± 368
20 1 6465 ± 368 0.15
17 2 7149± 400 0.01
14 3 6890 ± 440 0.04
13 4 6878 ± 456 0.05
Year 2
14 Baseline 7010± 367
14 5 6426 ± 367 0.79
9 6 6787 ± 458 1.00
7 7 6168 ± 518 0.68
4 8 6251 ± 705 0.88
Data are presented as LSM ± SE. Statistical analysis performed by General Linear Model using SYSTAT 12. Post hoc 
analysis was performed using Tukey’s Honestly-Significant-Difference Test. Statistical significance was set at p < 0.05; 
p values represent differences from annual baselines.
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E. Survey Instruments with Additional Results
102
D .l Workplace Wellness Program Health Questionnaire
A. Descriptive questions
1. M edical History
Condition Yes No
A sthm a
High b lood  pressure
H yperlip id em ia
Cardiovascular disease
Type 2 d iab etes
M eta b o lic  syndrom e
2. Medications (include oral contraceptives):
L is t:
3. Do you take any vitam in, m ineral, herbal o r o ther d ie tary  supplements (fo r  exam ple  




B. Q uantitative questions
4. During the past year, how many days did  illness o r  poor health  keep you from  w ork?
_________ N u m b e r o f  days
_________N o ne
_________D o n 't know
_________ I p re fe r to  g ive no answ er.
5. How long has it  been since you last visited a health  care practitioner fo r a check up?
_________W ith in  th e  past yea r
_________W ith in  th e  past five  years
_________D o n 't know
_________N ever
_________I p re fe r to  give no answ er.
6. W hat are your approxim ate annual out-of-pocket m edical costs?
_________N one
_________$0 - $ 5 0 0
_________$ 5 0 0 - $ 1 0 0 0
_________M o re  than  $ 1 0 0 0
_________D o n 't know
_________I p re fe r to  give no answ er.
7. Do you smoke cigarettes?
0 Yes -  H o w  m any in a typ ica l d a y ? __________________________
S No
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8. Put an X on the line below  to show, on a scale from  0 to 10, how  im portant i t  is for 
you to make lifestyle changes? (Lifestyle changes are changes to improve your
health, such as adjusting your diet, increasing your physical activity, and changing 
health-related behaviors.)
10
Not very important Somewhat important Very important
9. Put an X on the line to show how ready you are  r ig h t now, on a scale o f 0 to  10, to  m ake  
lifestyle changes.
10
Not very ready Somewhat ready Very ready
10. Put an X on the line to show how confident you are, on a scale o f 0 to 10, th a t you can m ake  
lifestyle changes?
10
Not very confident Somewhat confident Very confident
11. Put an X on the line  to  show your curren t level of stress, on a scale of 1 to  S.
0  5  1 0
Very relaxed Managing OK Very stressed
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C. Qualitative Questions
12. W hat lifestyle changes w ould you be w illin g  to  make?
13. W hat things m ight m ake i t  hard for you to  m ake lifestyle changes?
D. Participation Questions (at 24 months only)
14. Has partic ipation  in UNH Cooperative Extension W orkplace Wellness Study im pacted your  
lifestyle (d iet and activity choices, health  m aintenance and stress m anagem ent)?
a. Stayed the same
b. Improved a little
c. Improved somewhat
d. Improved a lot
e. Worsened a little
f. Worsened somewhat
g. Worsened a lot
h. Choose not to answer
15. Has partic ipation  in UNH Cooperative Extension W orkplace Wellness Study im pacted your 
health?
a. Stayed the same
b. Improved a little
c. Improved somewhat
d. Improved a lot
e. Worsened a little
f. Worsened somewhat
g. Worsened a lot
h. Choose not to answer
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16. Has participation in UNH Cooperative Extension Workplace Wellness Study impacted how
you feel?
a. Stayed the same
b. Improved a little
c. Improved somewhat
d. Improved a lot
e. Worsened a little
f. Worsened somewhat
g. Worsened a lot
h. Choose not to answer
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D. 2 Commitment to Lifestyle Changes and Perceived Barriers to Making Changes
Year 1 Year 2





















1.5 ±0.1 1.4 ±0 .2 1.5 ±0.1 1.8 ±0 .2 2.0 ±0 .3 1.6 ±0 .3 1.9 ± 0.3 1.9 ± 0 .3
Questionnaire variables in year 1 and year 2. General linear model performed using age and gender as covariates and 
post-hoc analyses were conducted using Tukey’s Honestly Significant Difference test. The level of statistical 
significance was set at p < 0.05.. Data are presented as LSM ± SE.
* p < 0.05 within group, M  p < 0.01 between groups,
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D. 3 Workplace Wellness Exit Survey
1. A. As a result of participating in the UNHCE Workplace Wellness program: What 
lifestyle changes (for example, healthy diet and activity choices, health maintenance 
and stress management) have you made? Please be specific.
B. As a result of participating in the UNHCE Workplace Wellness program: What 
health changes have you made? Please be specific.
2. Should UNHCE have a Workplace Wellness Program? Why or why not?
3. Please comment on the UNHCE Workplace Wellness program (what did you like; 
what did you dislike; do you have any suggestions for changes?
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D.4 Exit Survey Responses 2 and 3.
2. Should UNHCE have a Workplace Wellness 
Program? Why/Why not?
*» Positive impact on health
20 4 0  6 0  80
P ercen t o f  G ro u p  Responses
100
I Positive effect on work 
environment 
I Efficient use o f tim e and 
funds
I Needs more frequent 
meetings




■  C om p arison
■  In te rv e n tio n
Unfavorable Favorable b e t w e e n  g ro u p s
Pearson's Chi square analysis was used to examine category responses between groups. Data are presented as the 
percent of all responses within each group. The level of statistical significance was set at p < 0.05.
2. Responses to Exit Question “Should UNHCE have a Workplace Wellness Program". All categories are NS
3. Comments were classified as “Favorable” and “Unfavorable”.
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D.5 Exit Question 2 Responses
Should UNHCE have a Workplace W ellness Program? Why or why not?
Transcribed by J. Allen from Exit responses Fall 2008 of participants in the UNHCE WW
study
1. Yes! It would be great to have someone to provide wellness programs at 
UNHCE. Our schedules are atypical for UNH employees, and having someone 
dedicated to meeting our needs would help to keep staff healthier and more 
productive. It is far too easy to push these important topics to the side and let 
work dominate. Our crazy schedules and unusual hours can easily lead to bad 
eating and exercise habits.
2. I don't know.
3. Yes-encourage/remind us to make better choices; education about choices is 
good-1 learned things from the newsletters.
4. Nutrition information is very helpful. The tests and measurements are good 
assessments of your progress or lack of progress in maintaining overall good 
health. Knowing that a healthcare professional is interested in your progress 
helps you stay focused on good diet and healthy living.
5. Yes! hopefully a motivator for people to try to stay healthier.
6. Yes, increased productivity and decreased stress.
7. Yes- because there are changes I still need to make, despite my good weight 
blood profile etc. This keeps up my awareness.
8. Depends- If they can find a way to be supportive of ah county offices not just 
those with teleconferencing sites.
9. Yes, a wellness program would make all staff aware of their individual health and 
a healthy staff leads to less absence due to health problems that can be avoided 
or prevented.
10. Yes, with trying to balance work and family I do not have a lot of free time.
11. Yes- modeling for our own staff and others we work with and it's an investment in 
our employees health that we will recoup in their performance and stress level.
12. Yes, I think this program brought together a group that was focused on a benefit 
for their health. I was not in this group, however did eat lunch with others...I 
believe it would be a way of encouraging others to eat well and walk at lunch.
13. Yes, is there if we need it. Accurate info, and good opportunities for participation.
14. yes- good to be updated on blood pressure, cholesterol, glucose (screening).
15. Yes. We have high stress responsibilities along with high time expectations. 
However, along with that needs to be a supervisor who also encourages healthy 
practices, not one that gives it lip service then adds on more expectations.
I l l
16. yes, focus more on stress management- lack of support from organization.
17. yes- to set the standard for health choices/ lifestyle.
18. Yes! Having a workplace focused on employee wellness can have a significant 
impact on employee health, job satisfaction, & organizational effectiveness.
19. Yes! Most people need assistance sustaining long term wellness initiatives.
20. Yes! Everyone should have to participate in some way- even if its just as little as 
walking during a break, it's great to know your employer accepts and encourages 
healthy steps in your life.
21. Yes! It definitely motivated me to focus on my steps and diet. It was an easy way 
to monitor my blood work, etc. It helps to have others in the office working on 
being healthy. We try to serve healthy snacks at meetings, etc. Physical wellness 
affects attitudes and motivation and people work harder and smarter when they 
in good health.
22. Yes! I think it has been fun and a morale-booster. Promoting wellness sends a 
positive message of supporting all employees.
23. Yes- wellness improves staff energy & motivation- better productivity.
2 4 .1 think a WWP would be helpful as long as it provided sound, practical
information as well as social supports for participants. CE staff spend much of 
their day at work and I believe the social support system can be a big incentive 
for change.
25. Yes- would be great to have a program. Helpful for ways to combat day to day 
stress in the job!
26. It is a good idea. It would serve to keep people on track and aware of what they 
need to do to stay healthy or become more healthy.
27. Yes. It's easier to make changes to your daily routine when working with a group 
of people. In return the organization gets a staff who is healthy and happier. I 
would imagine this would equate to improved productivity and less missed days 
of work due to illness.
28. Yes! To help us keep reminders of the way we should be taking care of 
ourselves.
29. Yes, it gets people to walk and to watch what they eat.
30. Yes! It would encourage people-employees to continue to make healthier choices 
in food and encourage exercise. This would lead to a more positive work 
environment and less "sick'' time.
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3 1 .1 think all employers should have wellness programs feeling good about yourself 
can translate into feeling good about your job- healthy employees make less 
medical costs and less sick days.
32. Maybe it has been excellent in some ways. I have really valued the cholesterol 
screening and pedometer. The meetings were not frequent enough and not 
terribly valuable, though admittedly I didn't attend many because they took place 
during an aerobics class that I teach! The health monitoring was very valuable 
and would be great for UNHCE.
33. Yes, to keep the attention on what keeps us as healthy mindful-action groups.
34. Yes. It would help keep me more aware of my diet & healthy (or bad) habits. By 
meeting with others with similar goals it should help me make more progress. It is 
great to get your dietary habits assessed- 1 x per year would be good (or 2x). 
Lunchtime walking groups would be good.
35. It would be difficult unless all staff were charged to spend a certain amount of 
time daily/weekly in wellness related activities. Off campus sites don't have the 
facilities available.
36. This was a great program. By having the pic - tels and newsletters it really helped 
to focus on the most important things needed to be addressed for better health. 
There is information overload and you don't know what way to turn or what you 
should believe as it is always changing.
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D.6 Exit Question 3. Responses
Please comment on the UNHCE Workplace Wellness program. What did you
like; what did you dislike; do you have any suggestions for changes?
Transcribed by J. Allen from Exit responses Fall 2008 of participants in the UNHCE WW
study
1. 1.1 was not in the group that attended the monthly meetings and I would have 
liked to attend- so I disliked that part. 2. I liked the newsletters. They were 
interesting and informative. I liked Jorie’s very non-judgmental attitude. 3 . 1 liked 
the periodic testing. The results were consistent with those done by my doctor 
which gave me more confidences that my improvement was real.
2. Great project! Good luck with your PHD. It was all valuable - although for me the 
food recall was not so useful. I would have liked my beginning (entry) weight and 
body fat to compare 2 years later. I would have liked more information on the 
"peak flow meter" and what it all means.
3.
4. Hard to say anything since I was part of a control group.
5. Did not like being in the control group. Did enjoy working with Jorie Allen. She 
was terrific and didn't make me feel bad about not losing weight.
6. Great!
7. Newsletters=excellent I was in control group.
8. Everything went well, convenient locations for testing so made it easy to do.
9. Jorie was very pleasant and informative. Newsletter well written but not sent often 
enough.
10. Worked well for me.
11.1 didn't like the finger prick-1 liked the analyses every 6 months to show whether I 
was balanced/ where I should be or ready to! I liked the newsletter.
1 2 .1 didn't receive any newsletters or information- only participated in the testing. Not 
sure what happened-1 think there needs to be more confidentiality- though 
workplaces make that difficult. Glad to have participated. Would like a copy of the 
final report.
13. I'd like to see more interactive web-based education- such as online quizzes to go 
along with a healthy topic and newsletters far in place of the newsletter.
1 4 .1 enjoyed being a part of this program. It was great to be able to combine this 
program with my primary care and share the information across the physicians 
that I have been working with. I also learned information that benefited my 
position and my family.
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1 5 .1 liked trying new food products in the first year. I liked the convenience of the 
workplace testing and the pic-tel lunchtime meetings. Jorie was great to work 
with! I can't think of any improvements needed. I hope you get good data.
Thanks!
16. Education via video conference worked out well. I appreciate that much of the 
information went into specific detail. It was good to experience this as a county 
staff together.
17. Health assessments were great- No personal contact which could have lead to 
better outcomes-more changes, one time per month not enough and quarterly did 
not seem to have any effect at all for me.
1 8 .1 enjoyed it because I am interested in these topics. I would have liked to see 
more variety in & possibly research of the delivery methods that were used for the 
education delivery. I think it could have been more effective if it had engaged 
learners more actively. Thank you so much for the opportunity! I love having the 
regular health assessments & diet analysis.
1 9 .1 liked the monthly meetings and the information that was given. I didn't like 
keeping track of our activity.
20. Programs were diverse and informative. Screenings were helpful with immediate 
feedback on progress with cholesterol, blood sugar levels, etc. Though difficult 
with CE being so spread out, in-person meetings with our county participants 
would bring a different dimension to program.
2 1 .1 loved the meetings. Jorie did an excellent job on sharing information with the 
group. I only disliked that some of my co-workers were in the control group so we 
weren't able to share in the same experiences.
22. Jorie did an excellent job!
2 3 .1 liked the Program- Jorie did a great job. I like seeing how many steps I could do 
and improve my health- by doing steps- walk- at least three times a week.
2 4 .1 enjoyed learning about the latest in food nutrition and have tired to incorporate 
the information into my diet.
25. Regular checkups a good base line. Didn't like air intake to be. Newsletters were 
great. PicTel not a great way to import info.-also lots of technical problems
26. My suggestions would be to monitor activity (steps) for a defined 3-6week period, 
PAUSE, then monitor again for a short period 6months later. Perhaps it would 
defeat the purpose, but I think rewards would be helpful. For example, enter all 
the names of those who reputed steps in a drawing for fitness stuff, OR the 
highest steps wins, OR...I just think these would keep people reporting data. 
Another idea would be to issue some kind of challenge to participants- and 
reward meeting the challenge. For example eat 6 servings of vegetables daily for 
a week, enter the homecoming 5k, do 100,000 steps in 2weeks, etc. I really 
enjoyed being part of this and I learned about myself in the process. Thank you 
for the opportunity!!
115
27. Like the extra kick butt! Most staff in different manner...Eats were very good.
2 8 .1 did not make most of the lunch meetings, but those I did (or got the presentation 
for) were very helpful. The blood work was also very informative.
29. It was an interesting experience. I liked having the info available. It was 
manageable within the current schedule I keep.
3 0 .1 liked the whole program. I liked dedicating the 1 hour to the pictel to focus on 
health. It made you be dedicated to the dates we committed to. I liked the topic 
focus each session-1 would like to see periodic sessions we could participate in 
on pictel. I liked having my screening done on blood weight, etc. I fe lt it helped 
give me a personal health profile. Thank you for a great program Jorie. I am glad I 
got the chance to participate.
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E. Participant Clinical Report, Instructions and Self-reporting Forms
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E.1 NUTRITION AND HEALTH REPORT DISTRIBUTED TO PARTICIPANTS
Name:______________________________  Date:
County______________________________
Cooperative Extension Workplace Wellness 
NUTRITION AND HEALTH REPORT
MY




♦  N o rm al = 1 9 -2 4 .9
♦  O v e rw e ig h t = 2 5 -2 9 .9
♦  O bese = >30
BMI Category:
□ Normal
□  U n d e rw e ig h t





Normal Body Fat %
□ M a le : 1 2 -2 0 %
□ Fem ale: 2 0 -3 0 %
□ O bese
□ N o rm al
Waist
Circumference
♦ M e n  -  less th a n  4 0
inches
♦ W o m e n  -  less th a n  35
inches
□ Increased W a is t
C ircu m f
ere n c e
Blood Pressure
/
♦  N o rm al = < 1 2 0 /8 0
T argets  w h en  e le va te d :
♦  Less th a n  1 4 0 /9 0
♦  W ith  d iabetes , less th a n
1 3 0 /8 0
Blood Pressure Category: 
Normal = Less than 120/80
P re-hypertension  (1 2 0 -1 3 9  o r  
80-89)





♦  7 0 -1 0 0  m g /d l
FBG Category 
□  Normal
Im paired  fas ting  g lucose (1 0 0 -  
125)
Elevated (1 2 6  and  abo ve )
Total
Cholesterol
♦  D es irab le  = Less than  
2 0 0
Total Cholesterol Category: 
□  Desirable
□  B o rd erline  High = 2 0 0 -2 3 9
□  High = 2 4 0  and h ig her
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LDL-Cholesterol ♦  O p tim a l = Less th a n  100
♦  N e a r o p tim a l = 1 0 0 -1 2 9
♦  W ith  d ia b e te s  o r
co ro n ary  h eart  
disease = less th a n  100
LDL -  Cholesterol Category:
□ Optimal
u M e n  -  Low  = less th a n  
4 0
I  W o m e n  — Low  = less 
th a n  5 0
Page 2
N a m e ___________________________________________________________ Date
MY
RESULTS TARGETS AREA OF HEALTH RISK
HDL - Cholesterol ♦  O p tim a l = High = 60 and
higher
Targets  if low :
♦  M e n - 4 0  o r h igher and  
W o m e n  -  50 o r h igher
HDL -  Cholesterol Category:
□ Optimal
□ Above Risk Level
□ M e n  = Low  =
less th a n  40
□ W o m e n  — Low  =  less
th a n  50
Triglycerides ♦  N o rm a l = Less th a n  150
♦ TG Category:
□ Normal
□  B o rd erlin e  high = IS O -
199
□  H igh = 200-499
□  V e ry  h igh  = 500 and
h igher
Diet □  Fruits and vegetab les : 5 o r m o re
servings
a day
□  W h o le  gra in  breads and  cereals: 6-11
servings a day
□  L o w -fa t dairy: 2-3 servings a day
Calories:
P ro te in  gm  %
C arbos gm  %
Low  co n s u m p tio n  of:
□  Fruits and
veg e tab les
□  W h o le  gra in
b reads and  
cerea ls  
Z  Low  fa t  d a iry  
foods  
Z  M e a ts  and
p ro te in  foods
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Fat gm  % A lcohol gm
%
Fiber g m  S a tu ra ted  fa t  
%
O m eg a 6 :O m ega 3  P:S ra tio
V ita m in s  and M in e ra l fa llin g  b e lo w  th e  
RDA:
High co n s u m p tio n  of:
□  T o ta l fa t
□  S a tu ra te d  fa t
□  C h o les tero l
□  Sodium
Physical Activity □  3 0 -6 0  m in u tes  a day o f m o d era te  
a c tiv ity  m o st if not
all days
Low physical ac tiv ity
Metabolic Syndrome ♦  Low  risk o f m etab o lic  synd ro m e  
□ Indication of metabolic syndrome
□  P o ten tia l exists based  
on 3 or
m o re  ind icato rs:
Increased
□  W a is t c irc u m fe re n c e
□  Blood p ressure
□  Blood sugar






□  Less than 10% risk
%  risk
□  1 0 -2 0 %  
risk
□  G re a te r  




Lipid Profile and Blood Glucose Test Explanations
A Lipid Profile is a detailed measure of the fats in your blood. It consists of measuring your total 
cholesterol, HDL cholesterol, and triglycerides and calculating your LDL cholesterol. NCEP 
(National Cholesterol Education Program—a study by a panel of experts) ATP III Guidelines 
recommend a complete lipid profile as the initial test and testing every 6 weeks until lipid goals 
are met and every 4-6  months thereafter.
The "bad" cholesterol is called Low Density Lipoprotein (LDL) cholesterol. It contributes to the 
buildup of fat deposits in your arteries (atherosclerosis), which can cause decreased blood flow 
and heart attack.
About 65% o f the cholesterol in your blood is LDL An LDL of less than 130 mg/dL is 
desirable. If  you have a personal history o f coronary heart disease or diabetes, or if  you 
have multiple risk factors, your LDL should be below 100 mg/dL.
Cholesterol is one of several components that form your lipid profile. Total Cholesterol (TC) is a 
measure of the total amount of both "good" and "bad" cholesterol in your blood at a given time.
TC is measured in milligrams per deciliter (mg/dL). A TC of less than 200 mg/dL is desirable.
The "good" cholesterol is called High Density Lipoprotein (HDL) cholesterol. It removes excess 
cholesterol from your arteries and moves it to the liver for further processing or to be 
eliminated from the body.
The higher your HDL, the better. An HDL o f 60 mg/dL or higher is beneficial and 
considered a negative risk factor. An HDL of 40 mg/dL or lower is considered a risk 
factor fo r heart disease. A TC/HDL Ratio is total cholesterol divided by HDL cholesterol. Some 
healthcare professionals may use this ratio to assess risk for developing heart disease—lower 
ratios are associated with lower risk.
Glucose (GLU) is a measure of the sugar level in your blood. Fasting glucose levels should be 
below 100 mg/dL. If you are overweight or have a family history of diabetes, your glucose levels 
should be checked periodically to see if you have diabetes.
Triglycerides (TRG) are composed of fatty acids and glycerol. Like cholesterol, they circulate in 
your blood, but are stored in body fat and used when the body needs extra energy. While your 
triglyceride level can be significantly affected by how recently you've eaten, total cholesterol 
and HDL are only slightly affected.
After eating, your triglyceride level increases significantly. If your body processes the fa t  
efficiently, the level of triglycerides will decrease naturally. Your fasting triglyceride level should 
be below 150 mg/dL.
Your healthcare professional will carefully examine the test results of your lipid profile to fully 
assess your risk for coronary heart disease.
Source: Cholestech C o rp oratio n  2 005  w w w .ch o le s te ch .c o m
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Clinical Guidelines on the Identification, Evaluation, and 
Treatment of Overweight and Obesity in Adults: The 
Evidence Report (1)
Percentage Fat Mass Guidelines from the American Council of Exercise (2)
Waist Circumference 
Blood Pressure 






National Cholesterol Education Program Expert Panel on 
Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults (Adult Treatment Panel III) (3)
Diet
Physical Activity
U. S. Department of Agriculture and U. S. Department of 
Health and Human Services 2005 Dietary Guidelines for 
Americans, Dietary Reference Intakes (DRI) and 
Recommended Dietary Allowances (RDA)(4)
1. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and
Obesity in Adults: The Evidence Report. . In: National Heart LaBI, ed. NIH Publication 
No. 98 - 4083 ed: National Institutes of Health, 1998.
2. Muth ND. American Council on Exercise(ACE) Guidelines for body fat percentage. 
American Council on Exercise, 2006.
3. Executive Summary of The Third Report of The National Cholesterol Education Program 
(NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol 
In Adults (Adult Treatment Panel III). JAMA 2001 ;285:2486-97.
4. Dietary Guidelines for Americans 2005. In: Committee DGA, ed.:
U.S. Department of Health and Human Services, U.S. Department of Agriculture, 2000.
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E.3 INSTRUCTIONS FOR DIET RECORD
HOW  TO RECORD YOUR DAILY FOOD INTAKE
1. Record everything you eat or drink. Use a new diet intake sheet for each day; Indicate the 
name of the MEAL or the TIME of the snack, WHERE the food is provided or prepared 
(cafeteria, at home, vending machine, etc.), the FOOD ITEM, the AMOUNT eaten, and briefly 
describe how it was prepared (fried, boiled, broiled, etc). If the item was a brand name 
product, include the name.
2. Try to eat what you normally eat and record everything. This dietary survey will only be 
useful if you give an accurate account of what you eat.
3. List amounts in common household units that you are familiar with (e.g. teaspoons, cup, pat, 
ounce, inch, etc.).
4. MILK. - incidate whether milk is whole, low fat (1 % or 2%), or skim. Include flavoring if one 
is used.
5. VEGETABLES AND FRUITS - one average serving of cooked or canned fruits and vegetables is 
about a half cup. Fresh whole fruits and vegetables should be listed as small, medium or 
large. Be sure to indicate if sugar or syrup is added to fruit and list if any margarine, butter, 
cheese sauce or cream sauce are added to vegetables. When recording salad, list items 
comprising salad and be sure to include salad dressing used.
6. EGGS -  indicate method of preparation (scrambled, fried, poached, etc.) and the number 
eaten.
7. MEAT - POULTRY -FISH - indicate approximate size (e.g. 2 inch by 2 inch by 1 inch) or 
weight in ounces of the serving. Be sure to include gravy, sauce or breading added.
8. CHEESE - indicate kind, number of ounces, cubic inches, or slices and whether it is made 
from whole milk, part skim or is low calorie.
9. CEREAL - specify kind, whether cooked or dry and measured or estimated in terms of cups 
or ounces.
10. BREAD and ROLLS - specify kind (whole wheat, enriched white, rye, etc.), number and 
thickness of slices or size in inches. Remember to include in your description any butter or 
margarine used on bread.
11. BEVERAGES - include every item you drink including water. Be sure to record cream and 
sugar used in tea and coffee, whether juices are sweetened or unsweetened and whether soft 
drinks are diet or regular.
12. FATS - remember to record all the butter, margarine, oil and any other fats used in cooking 
or on food.
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13. VITAMINS and/or MINERAL SUPPLEMENTS - indicate type and quantity consumed and 
amount of nutrients provided.
14. MEDICATIONS - indicate name and prescribed dosage.
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PORTION GUIDE
SEVEN WAYS TO SIZE UP YOUR SERVINGS
M e a s u r e  f o o d  p o r t i o n s  s o  y o u  k n o w  e x a c t l y  h o w  m u c h  f o o d  y o u ' r e  e a t i n g
W h e n  a  f o o d  s c a l e  o r  m e a s u r i n g  c u p s  a r e n ' t  h a n d y ,  y o u  c a n  s t i l l  e s t i m a t e  y o u r  p o r t i o n  R e m e m b e r
1  3  o u n c e s  o f  m e a t  is  a b o u t  t h e  s i z e  
a n d  t h i c k n e s s  o f  a  d e c k  o f  p l a y i n g  
c a r d s  o r  a n  a u d i o t a p e  c a s s e t t e .
.  A  m e d i u m  a p p l e  o r  
p e a c h  i s  a b o u t  t h e  s i z e  
o f  a  t e n n i s  b a l l
U  o z  o f  c h e e s e  i s  a b o u t  
t h e  s i z e  o f  4  s t a c k e d  d i c e
•  •  m
•  •  H
•  •  i
•  •  i• * '
•  lh  c u p  o f  i c e  c r e a m  
i s  a b o u t  t h e  s i z e  o f  a  
r a c q u e t b a l !  o r  t e n n i s  b a l l
1 I c u p  o f  m a s h e d  p o t a t o e s  o r  
b r o c c o l i  i s  a b o u t  t h e  s i z e  o f  
y o u r  f i s t
1 1  t e a s p o o n  o f  b u t t e r  o r  
p e a n u t  b u t t e r  i s  a b o u t  t h e  
s i z e  o f  t h e  t i p  o f  y o u r  t h u m b
I o u n c e  o f  n u t s  o r  
s m a l l  c a n d i e s  e q u a l s  
o n e  h a n d f u l f l ® S o
MOST IMPORTANT
Especially if you're cutting 
cafcries. remember to keep 
your <4et nut ntious
02-4 servings from the M ilk Group for calcium 
12-3 se fvtr^s from the 
'  M eal Group for iron
o
V-5 servings from the
Vegetable Group for vitam in A 
2-4 servings from the
Fruit Group for vitam in C 
6-11 sen/ngs from the 
Grain Group for fiber
H *m *L  O f t m  O O U N O C fta i i »  a i
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FOOD RECORD SHEET
f / f lm  £ :  -----------------;— -------------------
Data:
H o a l <* 
T in a  ,
Kbara
E stan Food ite m taount
Hew









E. 4 PEAK FLOW REPORTING FORM
Essentials for getting quality measurements
•  You MUST breathe in as deeply as possible; this is critical for a reproducible 
measurement.
•  Put the mouth piece in your mouth and seal your lips, do not just press the 
mouthpiece up against you lips.
•  Wait for at least 30 seconds between tests
•  M easure vour Peak Flow Rate close to  th e  same tim e  each dav. One suggestion is 
to measure between 7and 9 a.m. and between 6 and 8 p.m.
A "normal" Peak Flow Rate is based on a person's age, height, sex and race. A standardized 
"normal" may be obtained from a chart comparing the patient with a population without 
breathing problems. Therefore, it is important for you and your doctor to discuss what is 
considered "normal" for you. 2006 American Lung Association®.
Instructions for performing a Peak Flow Rate Test are on the back side of this chart. Please do 
the test twice daily for a week, following these instructions. When the week is over, please mail 
the chart in the self-addressed stamped envelope provided. IMPORTANT: Don't throw your peak 
flow meter away. We will use it for repeat tests.
Name or ID i
Peak Expiratory Flow Rate
Date
Liters/min am pm am pm am pm am pm am pm am pm am pm
Forced Expiratory Volume in one second (FEVi)
Date




PROCEDURE FOR USING KOKO PRO 6 PEAK FLOW METER.
•  hold the meter away from the mouth (making sure the vents are not covered) and 
breathe in as DEEPLY as possible
• press the blue button on the device, and wait for the second beep
•  seal your lips around the mouthpiece
•  blast air out as fast and as far as you can, until the lungs are absolutely empty
•  in a few seconds the PEF and FEV1 readings will be displayed
•  repeat the measurement 3-times and record the highest test value
•  only record PEF and FEV1. The lower display will alternate values, be sure it is FEV1
that you record
The Display
Y o j i  PEF as 




PEF -  Peak Expiratory Flow rate
PEF is the highest rate of flow that you can exhale. It can occur at any time during your 
exhalation. PEF is a measure of the respiratory system's ability to clear air from the lungs. PEF 
depends on your body size, sex, race, gender and age. PEF is measured in liters per minute.
FEVi -  Forced Expiratory Volum e in th e  first second
FEVj is the volume of air that you exhaled during the first second. Measured in liters.
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E.5 Steps per minute for alternative activities
Source: UNH Center for Health Enhancement
These exercise equivalents were developed so participants who enjoy activities in 
addition to walking can log credit for those different activities. These are estimates. 2000
steps measured with a pedometer = 1 mile.
Aerobics, high impact 203 Golfing with a cart 101
Aerobics, low impact 145 Grocery shopping 67
Aerobics, step 246 Handball 348
Badminton, casual 131 Hiking, 10 -  20 lb load 217
Badminton, competitive 203 Hiking, 21 -  42 lb load 232
Basketball, game 230 Orienteering 260
Basketball, recreational 174 Painting 131
Bicycling, leisurely 116 Pilates 101
Bicycling, stationary 203 Ping Pong 116
Bowling 87 Racquetball, casual 203
Boxing 348 Racquetball, competitive 290
Canoeing, light 87 Raking leaves 125
Chopping wood, around home 174 Roller skating 203
Circuit training 232 Rowing, light 101
Cross-country skiing, intense 260 Rowing, moderate 203
Cross-country skiing, moderate 232 Running, 10 mph (6 min/mile) 463
Cross-country skiing, slow 203 Running, 8 mph (7.5 min /mile) 391
Dancing 131 Running, 6 mph (10 min/mile) 290
Downhill skiing 174 Running, 5 mph (12 min/ mile) 232
Elliptical trainer 203 Scuba diving 203
Firewood, carrying 145 Snow shoveling 174
Firewood, sawing with handsaw 217 Snowboarding, light 150
Firewood, stacking 145 Snowboarding, moderate 182
Football 260 Soccer, recreational 203
Gardening, light 116 Soccer, competitive 290
Gardening, heavy 174 Softball 145
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Gardening, weeding 131 Squash 348
Golfing, without cart 131 Stair climbing, machine 260
Stair climbing moderate 334 Jumping rope, fast 348
Stair climbing, slow 232 Jumping rope, moderate 290
Stair climbing, vigorous 434 Karate 290
Stretching 72 Kickboxing 290
Swimming, backstroke 203 Mowing 160
Swimming, breaststroke 290 Tae Kwon Do 290
Swimming, butterfly 319 Tai Chi 116
Swimming, freestyle 203 Tennis, doubles 174
Swimming, leisure 174 Tennis, singles 232
Swimming, treading water 116 Trampoline 101
Hiking, general 172 Volleyball, game 232
Horseback riding 116 Volleyball, leisure 87
Horseback riding, trotting 188 Wash the car 87
Housework, light 72 W ater aerobics 116
Housework, mopping floors 101 W ater skiing 174
Housework, scrubbing the floor 110 Wax the car 131
Housework, vacuuming 101 Weight lifting, moderate 87
Housework, washing windows 87 Weight lifting, vigorous 174
Ice skating 203 Yard work 145
Judo 290 Yoga 72
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